Nu Skin Enterprises (NUS) 10-K 16 Feb 22 2021 FY Annual report Financial data

Document and Entity Information

Document and Entity Information - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2021	Jan. 31, 2022	Jun. 30, 2021
Cover [Abstract]
Document Type	10-K
Amendment Flag	false
Document Annual Report	true
Document Period End Date	Dec. 31, 2021
Current Fiscal Year End Date	--12-31
Document Transition Report	false
Document Fiscal Year Focus	2021
Document Fiscal Period Focus	FY
Entity File Number	001-12421
Entity Registrant Name	NU SKIN ENTERPRISES, INC.
Entity Central Index Key	0001021561
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	87-0565309
Entity Address, Address Line One	75 West Center Street
Entity Address, City or Town	Provo
Entity Address, State or Province	UT
Entity Address, Postal Zip Code	84601
City Area Code	801
Local Phone Number	345-1000
Title of 12(b) Security	Class A Common Stock, $.001 par value
Trading Symbol	NUS
Security Exchange Name	NYSE
Entity Well-known Seasoned Issuer	Yes
Entity Voluntary Filers	No
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Large Accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
ICFR Auditor Attestation Flag	true
Entity Shell Company	false
Entity Public Float			$ 2,800
Entity Common Stock, Shares Outstanding		49,824,136
Auditor Firm ID	238
Auditor Name	PricewaterhouseCoopers LLP
Auditor Location	Salt Lake City, Utah

Consolidated Balance Sheets

Consolidated Balance Sheets - USD ($) $ in Thousands	Dec. 31, 2021	Dec. 31, 2020
Current assets
Cash and cash equivalents	$ 339,593	$ 402,683
Current investments	15,221	21,216
Accounts receivable, net	41,299	63,370
Inventories, net	399,931	314,366
Prepaid expenses and other	76,906	101,563
Total current assets	872,950	903,198
Property and equipment, net	453,674	468,181
Operating lease right-of-use assets	120,973	155,104
Goodwill	206,432	202,979
Other intangible assets, net	76,991	89,532
Other assets	175,460	138,082
Total assets	1,906,480	1,957,076
Current liabilities
Accounts payable	49,993	66,174
Accrued expenses	372,201	446,682
Current portion of long-term debt	107,500	30,000
Total current liabilities	529,694	542,856
Operating lease liabilities	88,759	112,275
Long-term debt	268,781	305,393
Other liabilities	106,474	102,281
Total liabilities	993,708	1,062,805
Commitments and contingencies (Notes 7 and 16)
Stockholders' equity
Class A common stock - 500 million shares authorized, $.001 par value, 90.6 million shares issued	91	91
Additional paid-in capital	601,703	579,801
Treasury stock, at cost - 40.7 million and 39.7 million shares	(1,526,860)	(1,461,593)
Accumulated other comprehensive loss	(73,896)	(64,768)
Retained earnings	1,911,734	1,840,740
Total stockholders' equity	912,772	894,271
Total liabilities and stockholders' equity	$ 1,906,480	$ 1,957,076

Consolidated Balance Sheets (Pa

Consolidated Balance Sheets (Parenthetical) - $ / shares shares in Millions	Dec. 31, 2021	Dec. 31, 2020
Stockholders' equity:
Common stock, shares authorized (in shares)	500	500
Common stock, par value (in dollars per share)	$ 0.001	$ 0.001
Common stock, shares issued (in shares)	90.6	90.6
Treasury stock (in shares)	40.7	39.7

Consolidated Statements of Inco

Consolidated Statements of Income - USD ($) shares in Thousands, $ in Thousands	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Consolidated Statements of Income [Abstract]
Revenue	$ 2,695,669	$ 2,581,934	$ 2,420,416
Cost of sales	675,223	658,028	581,420
Gross profit	2,020,446	1,923,906	1,838,996
Operating expenses:
Selling expenses	1,068,189	1,019,494	955,600
General and administrative expenses	666,395	646,848	615,970
Restructuring and impairment expenses	51,870	0	0
Total operating expenses	1,786,454	1,666,342	1,571,570
Operating income	233,992	257,564	267,426
Other income (expense), net (Note 17)	(1,533)	(1,332)	(12,254)
Income before provision for income taxes	232,459	256,232	255,172
Provision for income taxes	85,193	64,877	81,619
Net income	$ 147,266	$ 191,355	$ 173,553
Net income per share:
Basic (in dollars per share)	$ 2.93	$ 3.66	$ 3.13
Diluted (in dollars per share)	$ 2.86	$ 3.63	$ 3.10
Weighted-average common shares outstanding:
Basic (in shares)	50,193	52,296	55,518
Diluted (in shares)	51,427	52,765	55,927

Consolidated Statements of Comp

Consolidated Statements of Comprehensive Income - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Consolidated Statements of Comprehensive Income [Abstract]
Net income	$ 147,266	$ 191,355	$ 173,553
Other comprehensive income (loss):
Foreign currency translation adjustment, net of taxes of $429, $(299), and $(467) respectively	(13,476)	19,708	(5,358)
Net unrealized gains/(losses) on cash flow hedges, net of taxes of $(1,166), $(220) and $-, respectively	4,225	797	0
Less: Reclassification adjustment for realized losses/(gains) in current earnings on cash flow hedges, net of taxes of $(34), $(5), and $-, respectively	123	19	0
Other comprehensive (loss) income, net of tax	(9,128)	20,524	(5,358)
Comprehensive income	$ 138,138	$ 211,879	$ 168,195

Consolidated Statements of Co_2

Consolidated Statements of Comprehensive Income (Parenthetical) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Other comprehensive income (loss):
Foreign currency translation adjustment, tax	$ 429	$ (299)	$ (467)
Net unrealized gains/(losses) on cash flow hedges, tax	(1,166)	(220)	0
Reclassification adjustment for realized losses/(gains) in current earnings on cash flow hedges, tax	$ (34)	$ (5)	$ 0

Consolidated Statements of Stoc

Consolidated Statements of Stockholders' Equity - USD ($) $ in Thousands	Common Stock [Member]Class A [Member]	Additional Paid-in Capital [Member]	Treasury Stock, at Cost [Member]	Accumulated Other Comprehensive Loss [Member]	Retained Earnings [Member]	Total	Cumulative Effect Adjustment [Member]Common Stock [Member]Class A [Member]	Cumulative Effect Adjustment [Member]Additional Paid-in Capital [Member]	Cumulative Effect Adjustment [Member]Treasury Stock, at Cost [Member]	Cumulative Effect Adjustment [Member]Accumulated Other Comprehensive Loss [Member]	Cumulative Effect Adjustment [Member]Retained Earnings [Member]	Cumulative Effect Adjustment [Member]
Balance at beginning of period at Dec. 31, 2018	$ 91	$ 552,564	$ (1,326,605)	$ (79,934)	$ 1,635,751	$ 781,867
Balance at beginning of period (ASC 842 [Member]) at Dec. 31, 2018							$ 0	$ 0	$ 0	$ 0	$ 657	$ 657
Stockholders' Equity [Roll Forward]
Net income	0	0	0	0	173,553	173,553
Other comprehensive (loss) income, net of tax	0	0	0	(5,358)	0	(5,358)
Repurchase of Class A common stock (Note 8)	0	0	(825)	0	0	(825)
Exercise of employee stock options/vesting of stock awards	0	(4,929)	2,604	0	0	(2,325)
Stock-based compensation	0	9,909	0	0	0	9,909
Cash dividends	0	0	0	0	(82,189)	(82,189)
Balance at end of period at Dec. 31, 2019	91	557,544	(1,324,826)	(85,292)	1,727,772	875,289
Stockholders' Equity [Roll Forward]
Net income	0	0	0	0	191,355	191,355
Other comprehensive (loss) income, net of tax	0	0	0	20,524	0	20,524
Repurchase of Class A common stock (Note 8)	0	0	(144,334)	0	0	(144,334)
Exercise of employee stock options/vesting of stock awards	0	(1,803)	7,567	0	0	5,764
Stock-based compensation	0	24,060	0	0	0	24,060
Cash dividends	0	0	0	0	(78,387)	(78,387)
Balance at end of period at Dec. 31, 2020	91	579,801	(1,461,593)	(64,768)	1,840,740	894,271
Stockholders' Equity [Roll Forward]
Net income	0	0	0	0	147,266	147,266
Other comprehensive (loss) income, net of tax	0	0	0	(9,128)	0	(9,128)
Repurchase of Class A common stock (Note 8)	0	0	(80,420)	0	0	(80,420)
Exercise of employee stock options/vesting of stock awards	0	(1,292)	15,153	0	0	13,861
Stock-based compensation	0	23,194	0	0	0	23,194
Cash dividends	0	0	0	0	(76,272)	(76,272)
Balance at end of period at Dec. 31, 2021	$ 91	$ 601,703	$ (1,526,860)	$ (73,896)	$ 1,911,734	$ 912,772

Consolidated Statements of St_2

Consolidated Statements of Stockholder's Equity (Parenthetical) - shares shares in Millions	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Stockholders' Equity [Roll Forward]
Exercise of employee stock options (in shares)	0.7	0.4	0

Consolidated Statements of Cash

Consolidated Statements of Cash Flows - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Cash flows from operating activities:
Net income	$ 147,266	$ 191,355	$ 173,553
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	76,320	73,991	76,650
Non-cash lease expense	48,704	46,163	44,460
Stock-based compensation	23,194	24,060	9,909
Foreign currency (gains)/losses	7,056	(287)	3,829
Loss on disposal of assets	13,026	3,209	0
Impairment of fixed assets	31,892	0	0
Unrealized (gain)/losses on equity investments	(18,077)	0	0
Deferred taxes	5,821	(11,914)	1,965
Changes in operating assets and liabilities:
Accounts receivable, net	20,219	(11,207)	2,746
Inventories, net	(95,320)	(31,137)	18,446
Prepaid expenses and other	15,132	(153)	(17,435)
Other assets	(19,792)	(31,616)	(67,109)
Accounts payable	(13,279)	24,836	(7,184)
Accrued expenses	(104,992)	87,452	(86,997)
Other liabilities	4,412	14,389	25,098
Net cash provided by operating activities	141,582	379,141	177,931
Cash flows from investing activities:
Purchases of property and equipment	(68,615)	(63,823)	(66,067)
Proceeds on investment sales	15,094	14,037	11,160
Purchases of investments	(16,242)	(14,693)	(8,432)
Acquisitions (net of cash acquired)	(18,963)	(14,949)	(8,073)
Net cash used in investing activities	(88,726)	(79,428)	(71,412)
Cash flows from financing activities:
Exercise of employee stock options and taxes paid related to the net shares settlement of stock awards	13,861	5,764	(2,325)
Payment of cash dividends	(76,272)	(78,387)	(82,189)
Repurchase of shares of common stock	(80,420)	(144,334)	(825)
Finance lease principal payments	(1,871)	(709)	0
Payments on debt	(115,000)	(142,500)	(214,455)
Proceeds from debt	155,000	115,000	145,000
Net cash used in financing activities	(104,702)	(245,166)	(154,794)
Effect of exchange rate changes on cash	(11,244)	12,506	(3,006)
Net increase (decrease) in cash and cash equivalents	(63,090)	67,053	(51,281)
Cash and cash equivalents, beginning of period	402,683	335,630	386,911
Cash and cash equivalents, end of period	$ 339,593	$ 402,683	$ 335,630

The Company

The Company	12 Months Ended
	Dec. 31, 2021
The Company [Abstract]
The Company	1. The Company Nu Skin Enterprises, Inc. (the “Company”) is a holding company, with Nu Skin, being the primary operating unit. Nu Skin develops and distributes premium-quality, innovative beauty and wellness products that are sold worldwide under the Nu Skin, Pharmanex and ageLOC brands and a small number of other products and services. The Company reports revenue from ten segments, consisting of its geographic Nu Skin segments—Mainland China; Americas, which includes Canada, Latin America and the United States; South Korea; Southeast Asia/Pacific, which includes Australia, Indonesia, Malaysia, New Zealand, the Philippines, Singapore, Thailand and Vietnam; Europe, Middle East and Africa (“EMEA”), which includes markets in Europe as well as Israel, Russia and South Africa; Japan; and Hong Kong/Taiwan, which also includes Macau— — Manufacturing, which includes manufacturing and packaging subsidiaries it has acquired; Grow Tech, (the Company’s subsidiaries operating within each segment are collectively referred to as the “Subsidiaries”).

Summary of Significant Accounti

Summary of Significant Accounting Policies	12 Months Ended
	Dec. 31, 2021
Summary of Significant Accounting Policies [Abstract]
Summary of Significant Accounting Policies	2. Summary of Significant Accounting Policies Consolidation The consolidated financial statements include the accounts of the Company and the Subsidiaries. All significant intercompany accounts and transactions are eliminated in consolidation. Use of estimates The preparation of these financial statements, in conformity with accounting principles generally accepted in the United States of America (“U.S. GAAP”), required management to make estimates and assumptions that affected the reported Cash and cash equivalents Cash equivalents are short-term, highly liquid instruments with original maturities of 90 days or less. Accounts receivable Accounts receivable represents amounts owed to us through our operating activities and are presented net of allowance for doubtful accounts. Accounts receivable for core Nu Skin consists primarily of credit card receivables, while accounts receivable for our Rhyz investments consist primarily of trade receivables from customer sales. For the Company’s trade receivables from its Rhyz investment customers, the Company performs ongoing credit evaluations of its customers and maintains an allowance for expected credit losses. The allowance for expected credit losses represents the Company’s best estimate based on current and historical information, and reasonable and supportable forecasts of future events and circumstances. Inventories Inventories consist primarily of merchandise purchased for resale and are stated at the lower of standard cost or net realizable value, using a standard cost method which approximates the first-in, first-out method. The Company had reserves of its inventory carrying value totaling $ million and $ million as of December 31, 2021 and 2020, respectively. Inventories consist of the following (U.S. dollars in thousands): December 31, 2021 2020 Raw materials $ 179,891 $ 118,877 Finished goods 220,040 195,489 Total inventory, net $ 399,931 $ 314,366 Reserves of inventories consist of the following (U.S. dollars in thousands): 2021 2020 2019 Beginning balance $ 14,249 $ 12,295 $ 14,149 Additions 31,300 15,952 14,931 Write-offs (26,906 ) (13,998 ) (16,785 ) Ending balance $ 18,643 $ 14,249 $ 12,295 Prepaid expense and other Prepaid expenses and other consist of the following (U.S. dollars in thousands): December 31, 2021 2020 Deferred charges $ 14,266 $ 10,540 Prepaid income tax 2,784 — Prepaid inventory and import costs 6,087 4,123 Prepaid rent, insurance and other occupancy costs 3,690 9,182 Prepaid promotion and event cost 4,382 10,002 Prepaid other taxes 9,333 10,565 Prepaid software license 17,041 9,107 Deposits 1,158 33,312 Other 18,165 14,732 Total prepaid expense and other $ 76,906 $ 101,563 Property and equipment Property and equipment are stated at cost less accumulated depreciation. Depreciation is recorded using the straight-line method over the following estimated useful lives: Buildings 39 years Furniture and fixtures 5 - 7 years Computers and equipment 3 - 5 years Leasehold improvements Shorter of estimated useful life or lease term Scanners 3 years Vehicles 3 - 5 years Expenditures for maintenance and repairs are charged to expense as incurred. When an asset is sold or otherwise disposed of, the cost and associated accumulated depreciation are removed from the accounts and the resulting gain or loss is recognized in the statement of income. Property and equipment are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of such assets may not be recoverable. An impairment loss is recognized if the carrying amount of the asset exceeds its fair value. Leases On January 1, 2019, the Company adopted Topic 842 using the modified retrospective method. The Company determines if an arrangement is a lease at inception. Operating leases are included in operating lease right-of-use (“ROU”) assets, accrued expenses and operating lease liabilities on the consolidated balance sheets. Finance leases are included in other assets, accrued expenses and other liabilities on the consolidated balance sheets. Operating lease ROU assets represent the Company’s right to use an underlying asset for the lease term, and lease liabilities represent the Company’s obligation to make lease payments arising from the lease. ROU assets and lease liabilities are recognized at the lease commencement date based on the estimated present value of lease payments over the lease term. The Company uses its estimated incremental borrowing rate based on the information available at commencement date in determining the present value of future payments. The operating lease ROU assets also include any lease payments made and exclude lease incentives and initial direct costs incurred. The Company’s lease terms may include options to extend or terminate the lease when it is reasonably certain that the Company will exercise that option. Lease expense for minimum lease payments is recognized on a straight-line basis over the lease term. Leases with a term of months or less are not recorded on the balance sheet. The Company’s lease agreements do not contain any residual value guarantees. The Company has lease agreements with lease and non-lease components. The Company accounts for the lease and non-lease components as a single lease component. Goodwill and other intangible assets Goodwill is recorded when the cost of acquired businesses exceeds the fair value of the identifiable net assets acquired. Goodwill and intangible assets with indefinite useful lives are not amortized, but are assessed for impairment annually on October 1. In addition, impairment testing is conducted when events occur or circumstances change that would more likely than not reduce the fair value of a reporting unit below its carrying amount. Goodwill and intangible assets with indefinite useful lives would be written down to fair value if considered impaired. Guidance under Accounting Standards Codification (“ASC”) 350, Intangibles - Goodwill and Other In fiscal year 2020, a quantitative assessment was performed. fiscal years 2021 and 2019, The Company has historically evaluated its goodwill for impairment annually as of June 30 or more frequently if impairment indicators arose in accordance with Accounting Standards Codification (“ASC”) Topic 350, “Intangibles - Goodwill and Other.” In the fourth quarter of 2021, the Company changed the date of its annual assessment of goodwill to October 1 for all reporting units. The change in testing date for goodwill is a change in accounting principle, which management believes is preferable as the new date of the assessment better aligns with the Company’s budgeting process and will create a more efficient and timely process surrounding the impairment tests. The change in the assessment date does not delay, accelerate or avoid a potential impairment charge. The Company has determined that it is impracticable to objectively determine projected cash flows and related valuation estimates that would have been used as of each October 1 of prior reporting periods without the use of hindsight. As such, the Company prospectively applied the change in annual goodwill impairment testing date from October 1, 2021. No impairment was recognized during the years ended December 31, 2020 or 2019. As discussed further in Note 20 - Restructuring and Severance Charges, during the fourth quarter of fiscal year 2021, the Company recognized an $18.2 million goodwill and intangibles impairment charge related to the Grow Tech segment, which was included in Restructuring and impairment expenses in the consolidated statements of income. Equity Investments The Company holds strategic investments in other companies. These investments are accounted for under the measurement alternative described in ASC 321, Investments - Equity Securities Other assets Other assets consist of the following (U.S. dollars in thousands): December 31, 2021 2020 Deferred taxes $ 26,483 $ 35,414 Deposits for noncancelable operating leases 17,121 20,783 Cash surrender value for life insurance policies 49,851 45,453 Right-of-use assets, Financing, net 6,477 9,385 Long-term investments 35,868 11,344 Other 39,660 15,703 Total other assets $ 175,460 $ 138,082 Accrued expenses Accrued expenses consist of the following (U.S. dollars in thousands): December 31, 2021 2020 Accrued sales force commissions and other payments $ 139,793 $ 149,481 Accrued income taxes — 13,921 Accrued other taxes 31,135 45,018 Accrued payroll and other employee expenses 53,641 65,272 Accrued payable to vendors 45,347 47,201 Short-term operating lease liability 33,427 44,981 Accrued royalties 1,095 1,008 Sales return reserve 3,513 3,978 Deferred revenue 33,139 35,054 Other 31,111 40,768 Total accrued expenses $ 372,201 $ 446,682 Other liabilities Other liabilities consist of the following (U.S. dollars in thousands): December 31, 2021 2020 Deferred tax liabilities $ 2,385 $ 626 Reserve for other tax liabilities 21,774 22,731 Liability for deferred compensation plan 54,213 47,543 Contingent consideration 10,341 3,125 Finance lease liabilities 5,318 7,728 Asset retirement obligation 5,408 6,717 Other 7,035 13,811 Total other liabilities $ 106,474 $ 102,281 Revenue recognition Net sales include products and shipping and handling charges, net of estimates for product returns and any related sales incentives. Revenue is measured as the amount of consideration we expect to receive in exchange for transferring products. All revenue is recognized when we satisfy our performance obligations under the contract. The Company recognizes revenue by transferring the promised products to the customer, with revenue recognized at shipping point, the point in time the customer obtains control of the products. The Company recognizes revenue for shipping and handling charges at the time the products are delivered to or picked up by the customer. A reserve for product returns is accrued based on historical experience totaling $3.5 million and $4.0 million as of December 31, 2021 and 2020, respectively. During the years ended December 31, 2021, 2020 and 2019, the Company recorded sales returns of $52.1 million, $49.5 million and $52.2 million, respectively. The majority of the Company’s contracts have a single performance obligation and are short term in nature. Sales taxes and value added taxes in foreign jurisdictions that are collected from customers and remitted to governmental authorities are accounted for on a net basis and therefore are excluded from net sales. Contract Liabilities – Customer Loyalty Programs Contract liabilities, recorded as deferred revenue within the accrued expenses line in the consolidated balance sheets, include loyalty point program deferrals with certain customers which are accounted for as a reduction in the transaction price and are generally recognized as points are redeemed for additional products. The balance of deferred revenue related to contract liabilities was $22.0 million and $18.2 million as of December 31, 2021, and 2020, respectively. The contract liabilities impact to revenue for the years ended December 31, 2021, 2020 and 2019 was a decrease of $3.8 million, a decrease of $5.7 million and an increase of $1.3 million, respectively. Disaggregation of Revenue Please refer to Note 15 - Segment Information for revenue by segment and product line. Arrangements with Multiple Performance Obligations The Company’s contracts with customers may include multiple performance obligations. For such arrangements, the Company allocates revenues to each performance obligation based on its relative standalone selling price. The Company generally determines standalone selling prices based on the prices charged to customers for individual products sales to customers. Shipping and handling costs Shipping and handling costs are recorded as cost of sales and are expensed as incurred. Advertising expenses Advertising costs are expensed as incurred and are included in general and administrative expenses in the accompanying consolidated statements of income. Selling expenses Selling expenses are the Company’s most significant expense and are classified as operating expenses. Selling expenses include commissions the Company pays to its Brand Affiliates, as well as salaries, service fees, benefits, bonuses and other labor and unemployment expenses the Company pays to its sales force in Mainland China. Selling expenses do not include amounts the Company pays to its sales force based on their personal purchases; rather, such amounts are reflected as reductions to revenue.The term “Brand Affiliates” refers to members of the Company’s independent sales force in all of the Company’s markets besides Mainland China. In each of the Company’s markets, except Mainland China, Sales Leaders can earn “multi-level” compensation under the Company’s global sales compensation plan, including commissions for product sales to their consumer groups as well as the product sales made through the sales network they have developed and trained. The Company does not pay commissions on sales materials. Outside of Mainland China, the Company’s Brand Affiliates may make profits by purchasing the products from the Company at a discount and selling them to consumers with a mark-up. The Company does not account for nor pay additional commissions on these mark-ups received by Brand Affiliates. In many markets, the Company also allows individuals who are not members of its sales force, referred to as “preferred customers,” to buy products directly from the Company at a discount. The Company pays commissions on preferred customer purchases to the referring member of its sales force. Research and development Research and development costs are expensed as incurred and are included in general and administrative expenses in the accompanying consolidated statements of income and totaled $27.2 million, $23.3 million and $30.1 million in 2021, 2020 and 2019, respectively. Deferred tax assets and liabilities The Company accounts for income taxes in accordance with the Income Taxes Topic of the Financial Accounting Standards Codification. These standards establish financial accounting and reporting standards for the effects of income taxes that result from an enterprise’s activities during the current and preceding years. The Company takes an asset and liability approach for financial accounting and reporting of income taxes. The Company pays income taxes in many foreign jurisdictions based on the profits realized in those jurisdictions, which can be significantly impacted by terms of intercompany transactions between the Company and its foreign affiliates. Deferred tax assets and liabilities are created in this process. The Company has netted these deferred tax assets and deferred tax liabilities by jurisdiction. These deferred tax assets assume sufficient future earnings will exist for their realization, and are calculated using anticipated tax rates. Valuation allowances are established when necessary to reduce deferred tax assets to the amounts expected to be ultimately realized. Uncertain tax positions The Company files income tax returns in the U.S. federal jurisdiction, and in various state and foreign jurisdictions. In 2009, we entered into a voluntary program with the IRS called Compliance Assurance Process (“CAP”). Under the CAP program, the IRS audits the tax position of the identify and resolve any tax issues that may arise throughout the tax year. As of December 31, 2021, tax through 2020 audited and are effectively closed to further examination. For tax years 2021 and 2022, the Company is in the Bridge phase of the CAP program, pursuant to which the IRS will not accept disclosures, will not conduct reviews and will not provide letters of assurance for the year. There are limited circumstances that tax years in the Bridge phase will be opened for examination. we are 2018 2015 A reconciliation of the beginning and ending amount of unrecognized tax benefits included in other liabilities is as follows (U.S. dollars in thousands): 2021 2020 2019 Gross balance at January 1 $ 17,620 $ 13,507 $ 11,456 Increases related to prior year tax positions 4,146 2,958 775 Increases related to current year tax positions 1,794 3,302 2,273 Settlements (5,494 ) (1,091 ) — Decreases due to lapse of statutes of limitations (2,409 ) (1,377 ) (1,051 ) Currency adjustments (567 ) 321 54 Gross balance at December 31 $ 15,090 $ 17,620 $ 13,507 At December 31, 2021, the Company had $ million in unrecognized tax benefits of which $ million, if recognized, would affect the effective tax rate. In comparison, at 17.6 million in unrecognized tax benefits of which $ million, if recognized, would affect the effective tax rate. T Company’s gross unrecognized During the years ended December 31, 2021, and 2021, 2019, respectively. Net income per share Net income per share is computed based on the weighted-average number of common shares outstanding during the periods presented. Additionally, diluted earnings per share data gives effect to all potentially dilutive common shares that were outstanding during the periods presented (Note 8). Foreign currency translation A significant portion of the Company’s business operations occurs outside of the United States. The local currency of each of the Company’s Subsidiaries is considered its functional currency, except for the Company’s subsidiaries in Singapore and countries deemed highly inflationary where the U.S. dollar is used. All assets and liabilities are translated into U.S. dollars at exchange rates existing at the balance sheet dates, revenue and expenses are translated at weighted-average exchange rates and stockholders’ equity is recorded at historical exchange rates. The resulting foreign currency translation adjustments are recorded as a separate component of stockholders’ equity in the consolidated balance sheets and transaction gains and losses are included in other income (expense) in the consolidated statements of income Classification of a highly inflationary economy A market is considered to have a highly inflationary economy if it has a cumulative inflation rate of approximately 100% or more over a three-year period as well as other qualitative factors including historic inflation rate trends (increasing and decreasing), the capital intensiveness of the operation and other pertinent economic factors. The functional currency in highly inflationary economies is required to be the functional currency of the entity’s parent company, and transactions denominated in the local currency are remeasured to the functional currency. The remeasurement of local currency into U.S. dollars creates foreign currency transaction gains or losses, which the Company includes in its consolidated statements of income. In the second quarter of 2018, published inflation indices indicated that the three-year cumulative inflation in Argentina exceeded 100 percent, and as of July 1, 2018, we elected to adopt highly inflationary accounting for our subsidiary in Argentina. Under highly inflationary accounting, Argentina’s functional currency became the U.S. dollar, and its income statement and balance sheet have been measured in U.S. dollars using both current and historical rates of exchange. The effect of changes in exchange rates on peso-denominated monetary assets and liabilities has been reflected in earnings in Other income (expense), net and was not material. As of December 31, 2021, and 2020, Argentina had a small net peso monetary position. Net sales of Argentina were less than of our consolidated net sales for the year ended December 31, 2021, 2020 and 2019. Fair value of financial instruments The carrying value of financial instruments including cash and cash equivalents, accounts receivable and accounts payable approximate fair values due to the short-term nature of these instruments. The Company’s current investments as of December 31, 2021 include certificates of deposits and pre-refunded municipal bonds that are classified by management as held-to-maturity as the Company had the positive intent and ability to hold to maturity. The carrying value of these current investments approximate fair values due to the short-term nature of these instruments. As of December 31, 2021 and 2020, the fair value of debt was $377.5 million and $337.5 million, respectively. The estimated fair value of the Company’s debt is based on interest rates available for debt with similar terms and remaining maturities. The FASB Codification defines fair value as the price that would be received to sell an asset or paid to transfer a liability in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants at the measurement date. On a quarterly basis, the Company measures at fair value certain financial assets, including cash equivalents. Accounting standards specify a hierarchy of valuation techniques based on whether the inputs to those valuation techniques are observable or unobservable. Observable inputs reflect data obtained from independent sources, while unobservable inputs reflect the Company’s market assumptions. These two types of inputs have created the following fair-value hierarchy: ● Level 1 – quoted prices in active markets for identical assets or liabilities; ● Level 2 – inputs, other than the quoted prices in active markets, that are observable either directly or indirectly; ● Level 3 – unobservable inputs based on the Company’s own assumptions. Accounting standards permit companies, at their option, to measure many financial instruments and certain other items at fair value. The Company has elected not to apply the fair value option to existing eligible items. Stock-based compensation All share-based payments, including grants of stock options and restricted stock units, are required to be recognized in the Company’s financial statements based upon their respective grant date fair values. The Black-Scholes option-pricing model is used to estimate the fair value of stock options. The determination of the fair value of stock options is affected by the Company’s stock price and a number of assumptions, including expected volatility, expected life, risk-free interest rate and expected dividends. The Company uses historical volatility as the expected volatility assumption required in the Black-Scholes model. The expected life of the stock options is based on historical data trended into the future. The risk-free interest rate assumption is based on observed interest rates appropriate for the expected terms of the Company’s stock options. The fair value of the Company’s restricted stock units is based on the closing market price of its stock on the date of grant less the Company’s expected dividend yield. The Company recognizes stock-based compensation net of actual forfeitures over the requisite service period of the award. The total compensation expense related to equity compensation plans was $23.2 million, $24.1 million and $9.9 million for the years ended December 31, 2021, 2020 and 2019, respectively. In 2021, 2020 and 2019, these amounts reflect the reversal of , , and $ million, respectively, for certain performance-based awards that were no longer expected to vest. For the years ended December 31, 2021, 2020 and 2019, all stock-based compensation expense was recorded within general and administrative expenses. Reporting comprehensive income Comprehensive income is defined as the change in equity of a business enterprise during a period from transactions and other events and circumstances from non-owner sources, and it includes all changes in equity during a period except those resulting from investments by owners and distributions to owners. Derivative instruments and hedging activities FASB ASC 815, Derivatives and Hedging As required by ASC 815, the Company records all derivatives on the balance sheet at fair value. The accounting for changes in the fair value of derivatives depends on the intended use of the derivative, whether the Company has elected to designate a derivative in a hedging relationship and apply hedge accounting and whether the hedging relationship has satisfied the criteria necessary to apply hedge accounting. Derivatives designated and qualifying as a hedge of the exposure to changes in the fair value of an asset, liability, or firm commitment attributable to a particular risk, such as interest rate risk, are considered fair value hedges. Derivatives designated and qualifying as a hedge of the exposure to variability in expected future cash flows, or other types of forecasted transactions, are considered cash flow hedges. Derivatives may also be designated as hedges of the foreign currency exposure of a net investment in a foreign operation. Hedge accounting generally provides for the matching of the timing of gain or loss recognition on the hedging instrument with the recognition of the changes in the fair value of the hedged asset or liability that are attributable to the hedged risk in a fair value hedge or the earnings effect of the hedged forecasted transactions in a cash flow hedge. The Company may enter into derivative contracts that are intended to economically hedge certain of its risk, even though hedge accounting does not apply or the Company elects not to apply hedge accounting. In accordance with the FASB’s fair value measurement guidance in ASU 2011-04, the Company made an accounting policy election to measure the credit risk of its derivative financial instruments that are subject to master netting agreements on a net basis by counterparty portfolio. Recent accounting pronouncements In March 2020, the FASB issued, ASU 2020-04, Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting

Property and Equipment

Property and Equipment	12 Months Ended
	Dec. 31, 2021
Property and Equipment [Abstract]
Property and Equipment	3. Property and Equipment Property and equipment are comprised of the following (U.S. dollars in thousands): December 31, 2021 2020 Land $ 45,027 $ 45,242 Buildings 281,192 278,779 Construction in progress (1) 44,021 34,954 Furniture and fixtures 147,786 146,413 Computers and equipment 162,746 137,914 Leasehold improvements 129,675 164,963 Scanners 6,746 8,119 Vehicles 2,021 2,112 819,214 818,496 Less: accumulated depreciation (365,540 ) (350,315 ) $ 453,674 $ 468,181 (1) Construction in progress includes $11.0 million and $13.6 million as of December 31, 2021 and 2020, respectively, of eligible capitalized internal-use software development costs which will be reclassified to computers and equipment when placed into service. Depreciation of property and equipment totaled $62.9 million, $62.5 million and $61.7 million for the years ended December 31, 2021, 2020 and 2019, respectively. The Company recorded an impairment of $13.7 million for the year ended December 31, 2021 in connection with our fiscal year 2021 restructuring plan, see Note 20 – Restructuring and Severance Charges.

Goodwill

Goodwill	12 Months Ended
	Dec. 31, 2021
Goodwill [Abstract]
Goodwill	4. Goodwill The following table presents goodwill allocated to the Company’s reportable segments for the periods ended December 31, 2021 and 2020 (U.S. dollars in thousands): December 2021 2020 Nu Skin Mainland China $ 32,179 $ 32,179 Americas 9,449 9,449 South Korea 29,261 29,261 Southeast Asia/Pacific 18,537 18,537 EMEA 2,875 2,875 Japan 16,019 16,019 Hong Kong/Taiwan 6,634 6,634 Rhyz Investments Manufacturing 78,875 78,875 Grow Tech — 9,150 Rhyz Other 12,603 — Total $ 206,432 $ 202,979 All of the Company’s goodwill is recorded in U.S. dollar functional currency and allocated to the respective segments. Goodwill is not amortized; rather, it is subject to annual impairment In connection with the Company’s decision to exit the Grow Tech segment, a impairment charge was recorded in the year ended December see Note for further discussion regarding the restructuring and impairment of the Grow Tech segment. The increase in the Rhyz Other segment goodwill during the year ended December is due to an acquisition. See Note for further discussion of this acquisition.

Other Intangible Assets

Other Intangible Assets	12 Months Ended
	Dec. 31, 2021
Other Intangible Assets [Abstract]
Other Intangible Assets	5. Other Intangible Assets Other intangible assets consist of the following (U.S. dollars in thousands): Carrying Amount at December 31, 2021 2020 Indefinite life intangible assets: Trademarks and trade names $ 24,599 $ 24,599 Other indefinite lived intangibles — 3,763 $ 24,599 $ 28,362 December 31, 2021 December 31, 2020 Finite life intangible assets: Gross Carrying Amount Accumulated Amortization Gross Carrying Amount Accumulated Amortization Weighted- average Amortization Period Scanner technology $ 40,716 $ 40,716 $ 40,716 $ 40,716 18 years Developed technology 43,841 24,697 32,546 21,680 14 years Sales force network 11,598 11,598 11,598 11,598 15 years Trademarks 8,989 3,827 6,145 2,938 10 years Other 51,176 23,090 71,095 23,998 10 years $ 156,320 $ 103,928 $ 162,100 $ 100,930 14 years Amortization of finite-life intangible assets totaled $11.7 million, $9.8 million and $13.4 million for the years ended December 31, 2021, 2020 and 2019, respectively. The estimated annual amortization expense for each of the five succeeding fiscal years are as follows (U.S. dollars in thousands): Year Ending December 31, 2022 $ 9,282 2023 9,135 2024 8,625 2025 7,502 2026 7,135 Indefinite Finite life intangibles are amortized over their useful lives unless circumstances occur that cause the Company to revise such lives or review such assets for impairment. and a $5.2 million impairment charge related to other finite lived intangibles

Long-Term Debt

Long-Term Debt	12 Months Ended
	Dec. 31, 2021
Long-Term Debt [Abstract]
Long-Term Debt	6. Long-Term Debt On April 18, 2018, the Company entered into a Credit Agreement (the “Credit Agreement”) with several financial institutions as lenders and Bank of America, N.A., as administrative agent. The Credit Agreement provides for a $400 million term loan facility and a $350 million revolving credit facility, each with a term of five years. Both facilities bear interest at LIBOR , . The following table summarizes the Company’s debt facilities as of December 31, 2021 and 2020: Facility or Arrangement Original Principal Amount Balance as of December 31, 2021 (1)(2 ) Balance as of December 31, 2020 (1)(2) Interest Rate Repayment Terms Credit Agreement term loan facility $400.0 million $307.5 million $337.5 million Variable 35% of the principal amount is payable Credit Agreement revolving credit facility $70.0 million — Variable Revolving line of credit expires April 18, 2023. (1) As of December 31, 2021 and 2020, the current portion of the Company’s debt (i.e. becoming due in the next 12 months) included $37.5 million and $30.0 million, respectively, of the balance of its term loan under the Credit Agreement. (2) The carrying value of the debt reflects the amounts stated in the above table, less debt issuance costs of $1.2 million and $2.1 million as of December 31, 2021 and 2020, respectively, related to the Credit Agreement, which are not reflected in this table. Maturities of all long-term debt at December 31, 2021, are as follows (U.S. dollars in thousands): Year Ending December 31, 2022 $ 37,500 2023 270,000 2024 — 2025 — 2026 — Thereafter — Total (1) $ 307,500 (1) The carrying value of the debt reflects the amounts stated in the above table less debt issuance costs of $1.2 million, which is not reflected in this table.

Leases

Leases	12 Months Ended
	Dec. 31, 2021
Leases [Abstract]
Leases	7. Leases The Company has operating and finance leases for regional offices, manufacturing facilities, retail centers, distribution centers and certain equipment. The Company’s leases have remaining lease terms of year to years, some of which include options to extend the leases for up to years, and some of which include options to terminate the leases within year. As of December 31, 2021, the weighted average remaining lease term was 7.3 and 3.7 years for operating and finance leases, respectively. As of December 31, 2021, the weighted average discount rate was 3.8% and 3.8% for operating and finance leases, respectively. The components of lease expense were as follows (U.S. dollars in thousands): Year Ended December 31, 2021 2020 2019 Operating lease expense Operating lease cost $ 48,447 $ 51,828 $ 51,072 Variable lease cost 5,734 4,366 3,387 Short-term lease cost 592 1,056 169 Sublease income (5,663 ) (5,052 ) (5,743 ) Finance lease expense Amortization of right-of-use assets 2,398 1,023 — Interest on lease liabilities 319 154 — Total lease expense $ 51,827 $ 53,375 $ 48,885 Supplemental cash flow information related to leases was as follows (U.S. dollars in thousands): Year Ended December 31, 2021 2020 2019 Operating cash outflow from operating leases $ 51,570 $ 56,395 $ 54,993 Operating cash outflow from finance leases $ 322 $ 138 $ — Financing cash outflow from finance leases $ 1,871 $ 709 $ — Right-of-use assets obtained in exchange for operating lease obligations $ 25,427 $ 82,662 $ 184,502 Right-of-use assets obtained in exchange for finance lease obligations $ 74 $ 9,206 $ — Maturities of lease liabilities were as follows (U.S. dollars in thousands): Year Ending December 31, Operating Leases Finance Leases 2022 $ 35,960 $ 2,152 2023 24,806 2,064 2024 19,254 1,954 2025 14,336 1,381 2026 7,341 260 Thereafter 36,612 — Total 138,309 7,811 Less: Finance charges 17,658 548 Total principal liability $ 120,651 $ 7,263 The Company has additional lease liabilities of $5.2 million which have not yet commenced as of December 31, 2021, and as such, have not been recognized on the consolidated balance sheets.

Capital Stock

Capital Stock	12 Months Ended
	Dec. 31, 2021
Capital Stock [Abstract]
Capital Stock	8. Capital Stock The Company’s authorized capital stock consists of 25 million shares of preferred stock, par value $0.001 per share, 500 million shares of Class A common stock, par value $0.001 per share, and million shares of Class B common stock, par value $ per share Each share of Class A common stock entitles the holder to vote on matters submitted to a vote of the Company’s stockholders. Stock dividends of Class A common stock may be paid only to holders of Class A common stock. Class A common stock has no conversion rights. Weighted-average common shares outstanding The following is a reconciliation of the weighted-average common shares outstanding for purposes of computing basic and diluted net income per share (in thousands): Year Ended December 31, 2021 2020 2019 Basic weighted-average common shares outstanding 50,193 52,296 55,518 Effect of dilutive securities: Stock awards and options 1,234 469 409 Diluted weighted-average common shares outstanding 51,427 52,765 55,927 For the years ended December 31, 2021, 2020 and 2019, other stock options totaling 0.1 million, 0.4 million and 1.4 million, respectively, were excluded from the calculation of diluted earnings per share because they were anti-dilutive. Dividends Quarterly cash dividends for the years ended December 31, 2021 and 2020 totaled $76.3 million and $78.4 million or $0.38 per share in all quarters of 2021 and $0.375 for all quarters of 2020. In February 2022, the board of directors has declared a quarterly cash dividend of $0.385 per share of Class A common stock to be paid on March 9, 2022 to stockholders of record on February 28, 2022. Repurchases of common stock In July 2018, the Company’s board of directors approved a new repurchase plan with an authorization amount of $500 million. The repurchases are used primarily for strategic initiatives and to offset dilution from the Company’s equity incentive plans. During the years ended December 31, 2021, 2020 and 2019, the Company purchased 1.6 million, 5.1 million and 14,000 shares under the 2018 plan for $80.4 million, $144.3 million and $0.8 million, respectively. At December 31, 2021, $245.4 million was available for repurchases under the 2018 stock repurchase plan.

Stock-Based Compensation

Stock-Based Compensation	12 Months Ended
	Dec. 31, 2021
Stock-Based Compensation [Abstract]
Stock-Based Compensation	9. Stock–Based Compensation At December 31, 2021, the Company had the following stock-based employee compensation plans: Equity Incentive Plans In April 2010, the Company’s board of directors approved the Nu Skin Enterprises, Inc. 2010 Omnibus Incentive Plan (the “2010 Omnibus Incentive Plan”). This plan was approved by the Company’s stockholders at the Company’s 2010 Annual Meeting of Stockholders held in May 2010. The 2010 Omnibus Incentive Plan provides for granting of a variety of equity-based awards including stock options, stock appreciation rights, restricted stock, restricted stock units, other share-based awards, performance cash, performance shares and performance units to executives, other employees, independent consultants and directors of the Company and its subsidiaries. Options granted under the 2010 Omnibus Incentive Plan are generally non-qualified stock options, but the 2010 Omnibus Incentive Plan permits some stock options granted to qualify as “incentive stock options” under the U.S. Internal Revenue Code. The exercise price of a stock option generally is equal to the fair market value of the Company’s common stock on the stock option grant date. The contractual term of a stock option granted under the 2010 Omnibus Incentive Plan is seven years. Currently, all shares issued upon the exercise of stock options are from the Company’s treasury shares. Subject to certain adjustments, 7.0 million shares were authorized for issuance under the 2010 Omnibus Incentive Plan. On June 3, 2013, the Company’s stockholders approved an Amended and Restated 2010 Omnibus Incentive Plan, which among other things increased the number of shares available for awards by 3.2 million shares. On May 24, 2016, the Company’s stockholders approved a Second Amended and Restated 2010 Omnibus Incentive Plan, which among other things increased the number of shares available for awards by 3.8 million shares. On June the stockholders approved a Amended and Restated Omnibus Incentive Plan, which among other things increased the number of shares available for awards by shares. The fair value of stock option awards was estimated using the Black-Scholes option-pricing model with the following assumptions and weighted-average fair values as follows: December 31, Stock Options: 2021 2020 2019 Weighted-average grant date fair value of grants $ 16.10 $ 8.59 $ 19.72 Risk-free interest rate (1) 0.5 % 1.4 % 2.5 % Dividend yield (2) 2.9 % 2.9 % 2.7 % Expected volatility (3) 49.5 % 40.7 % 42.4 % Expected life in months (4) 56 months 59 months 60 months (1) The risk-free interest rate is based upon the rate on a zero-coupon U.S. Treasury bill, for periods within the contractual life of the option, in effect at the time of the grant. (2) The dividend yield is based on the average of historical stock prices and actual dividends paid. (3) Expected volatility is based on the historical volatility of the Company’s stock price, over a period similar to the expected life of the option. (4) The expected term of the option is based on the historical employee exercise behavior, the vesting terms of the respective option, and a contractual life of either seven or . Options under the plans as of December 31, 2021 and changes during the year ended December 31, 2021 were as follows: Shares (in thousands) Weighted- average Exercise Price Weighted- average Remaining Contractual Term Aggregate Intrinsic Value (in thousands) Options activity – service based Outstanding at December 31, 2020 770.6 $ 38.71 Granted — — Exercised (188.8 ) 37.74 Forfeited/cancelled/expired (43.6 ) 77.71 Outstanding at December 31, 2021 538.2 35.89 1.15 $ 8,303 Exercisable at December 31, 2021 538.2 35.89 1.15 8,303 Options activity – performance based Outstanding at December 31, 2020 2,398.0 $ 46.71 Granted 877.9 41.68 Exercised (297.6 ) 32.00 Forfeited/cancelled/expired (758.2 ) 63.77 Outstanding at December 31, 2021 2,220.1 40.87 4.62 $ 27,353 Exercisable at December 31, 2021 974.6 40.39 3.59 13,361 Options activity – all options Outstanding at December 31, 2020 3,168.6 $ 44.76 Granted 877.9 41.68 Exercised (486.4 ) 34.23 Forfeited/cancelled/expired (801.8 ) 64.53 Outstanding at December 31, 2021 2,758.3 39.90 3.95 $ 35,657 Exercisable at December 31, 2021 1,512.8 38.79 2.72 21,665 The aggregate intrinsic value in the table above represents the total pretax intrinsic value (the difference between the Company’s closing stock price on the last trading day of the respective years and the exercise price, multiplied by the number of in-the-money options) that would have been received by the option holders had all option holders exercised their options on December 31, 2021. This amount varies based on the fair market value of the Company’s stock. Cash proceeds, tax benefits and intrinsic value related to total stock options exercised during 2021, 2020 and 2019, were as follows (U.S. dollars in thousands): December 31, 2021 2020 2019 Cash proceeds from stock options exercised $ 14,435 $ 7,419 $ 368 Tax (expense) / benefit realized for stock options exercised 807 (459 ) 430 Intrinsic value of stock options exercised 8,402 5,232 934 Nonvested restricted stock awards as of December 31, 2021 and changes during the year ended December 31, 2021 were as follows: Number of Shares (in thousands) Weighted-average Grant Date Fair Value Nonvested at December 31, 2020 931.1 $ 46.38 Granted 380.4 50.39 Vested (307.6 ) 48.59 Forfeited (119.0 ) 45.95 Nonvested at December 31, 2021 884.9 $ 47.39 Stock-based compensation expense is recognized on a straight-line basis, except for performance-based awards for which expense is recognized using a graded-attribution method if the results are materially different than the straight-line method. The Company recognized none, $0.3 million and $2.6 million of expense related to service condition stock options in 2021, 2020 and 2019, respectively; and $15.4 million, $13.9 million and $11.5 million of expense related to service condition restricted stock units in 2021, 2020 and 2019, respectively. For performance stock options and performance stock units, an expense is recorded each period for the estimated expense associated with the projected achievement of the performance-based targets. The Company recognized $7.8 million of expense, $9.9 million of expense and $4.1 million of income related to performance stock options in 2021, 2020 and 2019, respectively; and none, none, and $0.1 million of expense related to performance stock units in 2021, 2020 and 2019, respectively. The amount in 2019 reflects the reversal of stock compensation for awards no longer expected to vest. As of December 31, 2021, there was $5.5 million of unrecognized stock-based compensation expense related to nonvested stock option awards. That cost is expected to be recognized over a weighted-average period of 1.3 years. As of December 31, 2021, there was $25.3 million of unrecognized stock-based compensation expense related to nonvested restricted stock awards. That cost is expected to be recognized over a weighted-average period of 2.4 years.

Fair Value and Equity Investmen

Fair Value and Equity Investments	12 Months Ended
	Dec. 31, 2021
Fair Value and Equity Investments [Abstract]
Fair Value and Equity Investments	10. Fair Value and Equity Investments Fair Value The carrying value of financial instruments including cash and cash equivalents, accounts receivable and accounts payable approximate fair values due to the short-term nature of these instruments. Fair value estimates are made at a specific point in time, based on relevant market information. The following tables present the fair value hierarchy for those assets and liabilities measured at fair value on a recurring basis (U.S. dollars in thousands): Fair Value at December 31, 2021 Level 1 Level 2 Level 3 Total Financial assets (liabilities): Cash equivalents and current investments $ 66,477 $ — $ — $ 66,477 Derivative financial instruments asset — 6,590 — 6,590 Life insurance contracts — — 49,851 49,851 Contingent consideration — — (10,341 ) (10,341 ) Total $ 66,477 $ 6,590 $ 39,510 $ 112,577 Fair Value at December 31, 2020 Level 1 Level 2 Level 3 Total Financial assets (liabilities): Cash equivalents and current investments $ 56,628 $ — $ — $ 56,628 Derivative financial instruments asset — 1,145 — 1,145 Life insurance contracts — — 45,453 45,453 Derivative financial instruments liability — (105 ) — (105 ) Contingent consideration — — (3,125 ) (3,125 ) Total $ 56,628 $ 1,040 $ 42,328 $ 99,996 The following methods and assumptions were used to determine the fair value of each class of assets and liabilities recorded at fair value in the consolidated balance sheets: Cash equivalents and current investments: Life insurance contracts: provisions of U.S. Derivative financial instruments asset and liability: Derivative financial instruments are measured at fair value based on observable market information and appropriate valuation methods. See Note , “Derivative Financial Instruments” for more information on derivative financial instruments. Contingent consideration: The following table provides a summary of changes in fair value of the Company’s Level 3 life insurance contracts (U.S. dollars in thousands): 2021 2020 Beginning balance at January 1 $ 45,453 $ 41,707 Actual return on plan assets 5,153 3,746 Purchases and issuances 6,261 — Sales and settlements (7,016 ) — Transfers into Level 3 — — Ending balance at December 31 $ 49,851 $ 45,453 The following table provides a summary of changes in fair value of the Company’s Level 3 contingent consideration (U.S. dollars in thousands): 2021 2020 Beginning balance at January 1 $ (3,125 ) $ — Additions from acquisitions (8,702 ) (3,125 ) Changes in fair value of contingent consideration 1,486 — Ending balance at December 31 $ (10,341 ) $ (3,125 ) Equity Investments The Company maintains equity investments in companies which are accounted for under the measurement alternative described in ASC 321-10-35-2 for equity securities that lack readily determinable fair values. The carrying amount of equity securities held by the Company without readily determinable fair values was $28.1 million as of December 31, 2021 and $5.0 million as of December 31, 2020. During the year ended December 31, 2021, the Company made an additional investment of $5.0 million. During the year ended December 31, 2021, the Company recognized $18.1 million of upward fair value adjustments, based on the third quarter of 2021 valuation of additional equity issued by the investee which was deemed to be an observable transaction of a similar investment under ASC 321. The gain was recorded within Other income (expense), net on the consolidated statements of income. The upward fair value adjustment represents a nonrecurring fair value measurement based on observable price changes and is classified as a level 2 fair value measurement.

Income Taxes

Income Taxes	12 Months Ended
	Dec. 31, 2021
Income Taxes [Abstract]
Income Taxes	11. Income Taxes Consolidated income before provision for income taxes consists of the following for the years ended December 31, 2021, 2020 and 2019 (U.S. dollars in thousands): 2021 2020 2019 U.S. $ 45,371 $ 71,138 $ 24,211 Foreign 187,088 185,094 230,961 Total $ 232,459 $ 256,232 $ 255,172 The provision for current and deferred taxes for the years ended December 31, 2021, 2020 and 2019 consists of the following (U.S. dollars in thousands): 2021 2020 2019 Current Federal $ — $ — $ — State 1,458 1,629 2,213 Foreign 77,393 77,079 79,694 78,851 78,708 81,907 Deferred Federal 3,705 (14,430 ) (8,878 ) State (38 ) (563 ) (473 ) Foreign 2,675 1,162 9,063 6,342 (13,831 ) (288 ) Provision for income taxes $ 85,193 $ 64,877 $ 81,619 The principal components of deferred taxes are as follows (U.S. dollars in thousands): Year Ended December 31, 2021 2020 Deferred tax assets: Inventory differences $ 5,859 $ 6,181 Foreign tax credit and other foreign benefits 69,401 57,720 Stock-based compensation 9,392 8,925 Accrued expenses not deductible until paid 36,401 42,694 Foreign currency exchange 605 1,403 Net operating losses 9,479 8,667 Capitalized research and development 22,962 23,019 R&D credit carryforward 1,451 1,229 Other 34 45 Gross deferred tax assets 155,584 149,883 Deferred tax liabilities: Foreign withholding taxes 15,412 20,207 Intangibles step-up 4,446 4,623 Overhead allocation to inventory 3,373 2,684 Amortization of intangibles 21,936 18,551 Other 6,133 1,690 Gross deferred tax liabilities 51,300 47,755 Valuation allowance (80,186 ) (67,340 ) Deferred taxes, net $ 24,098 $ 34,788 At December 31, 2021, the Company had foreign operating loss carryforwards of $26.7 million for tax purposes, which will be available to offset future taxable income. If not used, $12.4 million of carryforwards will expire between 2022 2031 tax effected the valuation on the net operating loss is $ million 2026 2030 The Company uses the tax law ordering approach when determining when excess tax benefits have been realized. The valuation allowances have been recognized for the foreign tax credit, the foreign net operating loss carryforwards, and the R&D credit carryforward. The valuation allowances were recognized for assets which it is more likely than not some portion or all of the deferred tax asset will not be realized. In making such determination, the Company considers all available positive and negative evidence, including future reversals of existing taxable temporary difference, projected future taxable income, tax planning strategies and recent financial operations. When the Company determines that there is sufficient positive evidence to utilize the foreign tax credits, the foreign net operating losses, or the R&D credit carryforward, the valuation will be released which would reduce the provision for income taxes. The deferred tax asset valuation adjustments for the years ended December 31, 2021, 2020 and 2019 are as follows (U.S. dollars in thousands): Year Ended December 31, 2021 2020 2019 Balance at the beginning of period $ 67,340 $ 77,042 $ 68,697 Additions charged to cost and expenses 12,674 (1) 2,154 (4) 10,913 (6) Decreases — (2) (12,100 ) (5) (3,343 ) (7) Adjustments 172 (3) 244 (3) 775 (3) Balance at the end of the period $ 80,186 $ 67,340 $ 77,042 (1) Increase $11.9 million that was recorded on the foreign tax credit carryforward due to the disposal of the Companies Grow Tech segment. The additional amount is due to (2) No decreases in 2021. (3) Represents the net currency effects of translating valuation allowances at current rates of exchange. (4) Increase net operating losses in foreign markets . (5) The . (6) Increase in valuation is due primarily to $9.8 million that was recorded on the foreign tax credit carryforward. The additional amount is due to net operating losses in foreign markets. (7) The . The components of deferred taxes, net on a jurisdiction basis are as follows (U.S. dollars in thousands): Year Ended December 31, 2021 2020 Net noncurrent deferred tax assets $ 26,483 $ 35,414 Net noncurrent deferred tax liabilities 2,385 626 Deferred taxes, net $ 24,098 $ 34,788 The Company is subject to regular audits by federal, state and foreign tax authorities. These audits may result in proposed assessments that may result in additional tax liabilities. The actual tax rate for the years ended December 31, 2021, 2020 and 2019 compared to the statutory U.S. Federal tax rate is as follows: Year Ended December 31, 2021 2020 2019 Income taxes at statutory rate 21.00 % 21.00 % 21.00 % Excess tax benefit from equity award (0.19 )% 0.70 % 0.02 % Non-U.S. income taxed at different rates 6.06 % 3.37 % 3.09 % Foreign withholding taxes 4.71 % 5.21 % 4.10 % Change in reserve for uncertain tax positions (0.06 )% 1.98 % 1.07 % Valuation allowance recognized foreign tax credit & others 5.12 % (4.59 )% 2.56 % Foreign-Derived Intangible Income (FDII) (0.87 )% (2.78 )% (0.70 )% Other 0.88 % 0.43 % 0.85 % 36.65 % 25.32 % 31.99 % The reflected the utilization of The increase in the effective tax rate for 2021 was primarily caused by the disposal of the Company’s Grow Tech segment which reduced the utilization of foreign tax credits and increased the Company’s valuation allowance The cumulative amount of undistributed earnings of the Company’s non-U.S. Subsidiaries held for indefinite reinvestment is approximately $60.0 million, at December 31, 2021. If this amount were repatriated to the United States, the amount of incremental taxes would be approximately $6.0 million.

Employee Benefit Plan

Employee Benefit Plan	12 Months Ended
	Dec. 31, 2021
Employee Benefit Plan [Abstract]
Employee Benefit Plan	12. Employee Benefit Plan The Company has a 401(k) defined-contribution plan which permits participating employees to defer up to a maximum of 100% of their compensation, subject to limitations established by the IRS. Employees age 18 and older are eligible to contribute to the plan starting the first day of employment. Upon employment, employees are eligible to receive matching contributions from the Company. In 2021, 2020, and 2019 the Company matched employees’ base pay up to 4% each year. The Company’s matching contributions cliff vest after two years of service. The Company recorded compensation expense of $4.8 million, $4.4 million and $3.7 million for the years ended December 31, 2021, 2020 and 2019, respectively, related to its contributions to the plan. The Company may make additional discretionary contributions to the plan of up to 10% of employees’ base pay. The Company’s discretionary contributions vest 20% per year for an employee’s first five years of service. For the years ended December 31, 2021, 2020 and 2019 the Company did not make any additional discretionary contributions.

Deferred Compensation Plan

Deferred Compensation Plan	12 Months Ended
	Dec. 31, 2021
Deferred Compensation Plan [Abstract]
Deferred Compensation Plan	13. Deferred Compensation Plan The Company has a deferred compensation plan for select management personnel, highly compensated employees, and members of the Company’s board of directors. Under this plan, the Company may make discretionary contributions to participants’ deferred compensation accounts; prior to 2021, contributed for participants above a specified compensation level. on or prior to December 31, 2020 will Effective January 1, 2021, the Company amended its deferred compensation plan. Under the revision, the Company shall make matching contributions up to 5% of certain participants’ base salary. The revision continues to authorize the Company to make discretionary contributions to participants’ accounts , though the Company is not obligated to make these contributions The Company recorded compensation expense of $4.0 million, $2.3 million and $1.8 million for the years ended December 31, 2021, 2020 and 2019, respectively, related to its contributions to the plan. The total long-term deferred compensation liability under the deferred compensation plan was $54.2 million and $47.5 million for the years ended December 31, 2021 and 2020, respectively, related to its contributions to the plan and is included in other long-term liabilities. All benefits under the deferred compensation plan are unsecured obligations of the Company. The Company has contributed assets to a “rabbi trust” for the payment of benefits under the deferred compensation plan. As the assets of the trust are available to satisfy the claims of general creditors if the Company becomes insolvent, the amounts held in the trust are accounted for as an investment on the Company’s consolidated balance sheets of $49.9 million and $45.5 million for the years ended December 31, 2021 and 2020, respectively.

Derivative Financial Instrument

Derivative Financial Instruments	12 Months Ended
	Dec. 31, 2021
Derivative Financial Instruments [Abstract]
Derivative Financial Instruments	14. Derivative Financial Instruments Risk Management Objective of Using Derivatives The Company is exposed to certain risks arising from both its business operations and economic conditions. The Company principally manages its exposures to a wide variety of business and operational risks through management of its core business activities. The Company manages economic risks, including interest rate, liquidity, and credit risk primarily by managing the amount, sources, and duration of its assets and liabilities and the use of derivative financial instruments. Specifically, the Company enters into derivative financial instruments to manage exposures that arise from business activities that result in the receipt or payment of future known and uncertain cash amounts, the value of which are determined by interest rates. The Company’s derivative financial instruments are used to manage differences in the amount, timing, and duration of the Company’s known or expected cash receipts and its known or expected cash payments principally related to the Company’s borrowings. Cash Flow Hedges of Interest Rate Risk The Company’s objectives in using interest rate derivatives are to add stability to interest expense and to manage its exposure to interest rate movements. To accomplish this objective, the Company primarily uses interest rate swaps as part of its interest rate risk management strategy. Interest rate swaps designated as cash flow hedges involve the receipt of variable-rate amounts from a counterparty in exchange for the Company making fixed-rate payments over the life of the agreements without exchange of the underlying notional amount. During 2021, such derivatives were used to hedge the variable cash flows associated with existing variable-rate debt. For derivatives designated and that qualify as cash flow hedges of interest rate risk, the gain or loss on the derivative is recorded in Accumulated Other Comprehensive Income and subsequently reclassified into interest expense/income in the same period(s) during which the hedged transaction affects earnings. Amounts reported in accumulated other comprehensive income related to derivatives will be reclassified to interest expense/income as interest payments are made/received on the Company’s variable-rate debt. During the next twelve months, the Company estimates that an additional $557 thousand will be reclassified as a reduction to interest expense. As of December 31, 2021, the Company had four outstanding interest rate derivatives that were designated as cash flow hedges of interest rate risk with a total notional amount of $200 million. Fair Values of Derivative Instruments on the Balance Sheet The table below presents the fair value of the Company’s derivative financial instruments as well as their classification on the Balance Sheet: Fair Values of Derivative Instruments December 31, Derivatives in Cash Flow Hedging Relationships: Balance Sheet Location 2021 2020 Interest Rate Swap - Asset Prepaid expenses and other $ 557 $ — Interest Rate Swap - Asset Other assets $ 6,033 $ 1,145 Interest Rate Swap - Liability Accrued expenses $ — $ 104 Effect of Cash Flow Hedge Accounting on Accumulated Other Comprehensive Income The tables below present the effect of cash flow hedge accounting on Accumulated Other Comprehensive Income. Amount of Gain (Loss) Recognized in OCI on Derivative Year Ended December 31, Derivatives in Cash Flow Hedging Instruments: 2021 2020 2019 Interest Rate Swaps $ 5,391 $ 1,017 $ — Amount of Gain (Loss) Reclassified from Accumulated Other Comprehensive Loss into Income Year Ended December 31, Derivatives Designated as Hedging Instruments: Income Statement 2021 2020 2019 Interest Rate Swaps Other income/(expense) $ (157 ) $ (24 ) $ —

Segment Information

Segment Information	12 Months Ended
	Dec. 31, 2021
Segment Information [Abstract]
Segment Information	15. Segment Information The Company reports revenue from 10 segments, consisting of its seven geographic Nu Skin segments—Mainland China, Americas, South Korea, Southeast Asia/Pacific, EMEA, Japan, and Hong Kong/Taiwan—and three Rhyz Investments segments—Manufacturing, Grow Tech and Rhyz other. The Nu Skin other category includes miscellaneous corporate revenue and related adjustments. The Rhyz other segment includes other investments by our Rhyz strategic investment arm. These segments reflect the way the chief operating decision maker evaluates the Company’s business performance and allocates resources. Reported revenue includes only the revenue generated by sales to external customers. Profitability by segment as determined under US GAAP is driven primarily by the Company’s transfer pricing policies. Segment contribution, which is the Company’s segment profitability metric presented in the table below, excludes certain intercompany charges, specifically royalties, license fees, transfer pricing, discrete charges and other miscellaneous items. These charges have been included in Corporate and other expenses. Corporate and other expenses also include costs related to the Company’s executive and administrative offices, information technology, research and development, and marketing and supply chain functions not recorded at the segment level. In the first quarter of 2021, as a result of a change in the Company’s transfer pricing policies in the Americas, the segment contribution calculation has been adjusted. The prior year Americas and Corporate and other has been recast to conform with the new policy. Beginning in July 2021, the Company has changed how the chief operating decision maker manages and reports the Pacific market. The Pacific market will be now be reported with the Southeast Asia segment and no longer with the Americas segment. Segment information has been recast to reflect the move of the Pacific components from the “America/Pacific” operating segment to the “Southeast Asia/Pacific” operating segment. Consolidated financial information is not affected. The accounting policies of the segments are the same as those described in Note 2, “Summary of Significant Accounting Policies.” The Company evaluates the performance of its segments based on revenue and segment contribution. Each segment records direct expenses related to its employees and its operations. Summarized financial information for the Company’s reportable segments is shown in the following tables. Asset information is not reviewed or included with the Company’s internal management reporting. Therefore, the Company has not disclosed asset information for each reportable segment. Revenue by Segment Year Ended December 31, (U.S. dollars in thousands) 2021 2020 2019 Nu Skin Mainland China $ 568,774 $ 625,538 $ 722,526 Americas 547,755 453,022 304,422 South Korea 354,252 326,478 329,978 Southeast Asia/Pacific 336,651 361,627 346,276 EMEA 283,200 230,246 167,165 Japan 266,216 273,681 260,039 Hong Kong/Taiwan 162,611 161,117 166,335 Nu Skin Other 1,549 (17 ) 1,621 Total Nu Skin 2,521,008 2,431,692 2,298,362 Rhyz Investments Manufacturing (1) 172,120 149,339 121,917 Grow Tech 2,104 903 137 Rhyz Other 437 — — Total Rhyz Investments 174,661 150,242 122,054 Total $ 2,695,669 $ 2,581,934 $ 2,420,416 (1) The Manufacturing segment had $84.5 million, $39.4 million and $25.7 million of intersegment revenue for the years ended December 31, 2021, 2020 and 2019, respectively. Intersegment revenue is eliminated in the consolidated financial statements and in the table above. Segment Contribution Year Ended December 31, (U.S. dollars in thousands) 2021 2020 2019 Nu Skin Mainland China $ 151,645 $ 181,024 $ 191,570 Americas 116,265 86,386 52,135 South Korea 114,034 100,933 99,892 Southeast Asia/Pacific 81,779 87,753 90,666 EMEA 41,988 24,078 10,195 Japan 67,511 68,027 61,081 Hong Kong/Taiwan 37,330 33,466 33,569 Nu Skin contribution 610,552 573,039 539,108 Rhyz Investments Manufacturing 18,346 21,168 15,693 Grow Tech (83,907 ) (22,430 ) (19,509 ) Rhyz Other (1,813 ) — — Rhyz Investments contribution (67,374 ) (1,262 ) (3,816 ) Total segment contribution 543,178 571,777 535,292 Corporate and other (309,186 ) (314,213 ) (267,866 ) Operating income 233,992 257,564 267,426 Other income (expense) (1,533 ) (1,332 ) (12,254 ) Income before provision for income taxes $ 232,459 $ 256,232 $ 255,172 Depreciation and Amortization Year Ended December 31, (U.S. dollars in thousands) 2021 2020 2019 Nu Skin Mainland China $ 13,345 $ 11,056 $ 10,496 Americas 871 984 767 South Korea 3,279 3,620 5,093 Southeast Asia/Pacific 1,450 1,670 2,012 EMEA 1,106 1,017 1,260 Japan 906 1,876 3,866 Hong Kong/Taiwan 3,637 2,912 2,310 Total Nu Skin 24,594 23,135 25,804 Rhyz Investments Manufacturing 11,765 8,081 6,689 Grow Tech 4,888 5,092 4,008 Other Rhyz Investments 1,579 — — Total Rhyz Investments 18,232 13,173 10,697 Corporate and other 33,494 37,683 40,149 Total $ 76,320 $ 73,991 $ 76,650 Capital Expenditures Year Ended December 31, (U.S. dollars in thousands) 2021 2020 2019 Nu Skin Mainland China $ 24,382 $ 19,363 $ 14,814 Americas 714 1,061 1,283 South Korea 854 1,420 1,223 Southeast Asia/Pacific 1,330 2,197 816 EMEA 1,242 1,875 364 Japan 194 3,128 1,528 Hong Kong/Taiwan 736 708 3,203 Total Nu Skin 29,452 29,752 23,231 Rhyz Investments Manufacturing 14,022 14,366 6,595 Grow Tech 1,683 2,499 6,938 Other Rhyz Investments — — — Total Rhyz Investments 15,705 16,865 13,533 Corporate and other 23,458 17,206 29,303 Total $ 68,615 $ 63,823 $ 66,067 Revenue by Major Market A major market is defined as one with total revenue greater than 10% of consolidated total revenue. Based on this criteria, the Company has identified four major markets: Mainland China, South Korea, United States, and Japan. There are approximately 45 other markets, each of which individually is less than 10%. Year Ended December 31, (U.S. dollars in thousands) 2021 2020 2019 Mainland China $ 568,774 $ 625,538 $ 722,526 South Korea 354,252 326,478 329,978 Japan 266,216 273,681 260,039 United States 540,253 425,155 324,727 All others 966,174 931,082 783,146 Total $ 2,695,669 $ 2,581,934 $ 2,420,416 Revenue by Product Line Year Ended December 31, (U.S. dollars in thousands) 2021 2020 2019 Beauty (1) $ 1,442,659 $ 1,491,803 $ 1,423,485 Wellness (1) 1,062,549 922,553 863,125 Other (2) 190,461 167,578 133,806 Total $ 2,695,669 $ 2,581,934 $ 2,420,416 (1) Includes sales of beauty and wellness products in the core Nu Skin business. The beauty category includes $658 million, $712 million, $618 million in sales of devices and related consumables for the years ended December 31, 2021, 2020 and 2019, respectively. (2) Other includes the external revenue from the Rhyz companies along with a limited number of other products and services, including household products and technology services. Long-Lived Assets by Major Market A major market is defined as a market with long-lived assets greater than 10% of consolidated long-lived assets and also includes the Company’s country of domicile (the United States). Long-lived assets in Mainland China consist primarily of property, plant and equipment related to manufacturing, distribution facilities and the Mainland China headquarters. Long-lived assets in the United States consist primarily of property, plant and equipment, including the Company’s corporate offices and distribution facilities. Long-lived assets by major market are set forth below for the periods ended December 31, 2021, 2020 and 2019: Year Ended December 31, (U.S. dollars in thousands) 2021 2020 2019 United States $ 335,020 $ 348,028 $ 354,410 Mainland China 149,124 152,312 136,845 South Korea 25,364 39,104 35,286 Japan 23,929 31,085 12,015 All others 47,687 62,141 59,374 Total $ 581,124 $ 632,670 $ 597,930

Commitments and Contingencies

Commitments and Contingencies	12 Months Ended
	Dec. 31, 2021
Commitments and Contingencies [Abstract]
Commitments and Contingencies	16. Commitments and Contingencies The Company is subject to government regulations pertaining to product formulation, labeling and packaging, product claims and advertising, and the Company’s direct selling system. The Company is also subject to the jurisdiction of numerous foreign tax and customs authorities. Any assertions or determination that either the Company or the Company’s sales force is not in compliance with existing statutes, laws, rules or regulations could have a material adverse effect on the Company’s operations. In addition, in any country or jurisdiction, the adoption of new statutes, laws, rules or regulations or changes in the interpretation of existing statutes, laws, rules or regulations could have a material adverse effect on the Company and its operations. No assurance can be given that the Company’s compliance with applicable statutes, laws, rules and regulations will not be challenged by foreign authorities or that such challenges will not have a material adverse effect on the Company’s financial position, results of operations or cash flows. The Company and its Subsidiaries are defendants in litigation, investigations and other proceedings involving various matters. The Company is subject to loss contingencies, including various legal and regulatory proceedings, asserted and potential claims that arise in the ordinary course of business. An estimated loss from such contingencies is recognized as a charge to income if it is probable that a liability has been incurred and the amount of the loss can be reasonably estimated. The Company is subject to regular audits by federal, state and foreign tax authorities. These audits may result in additional tax liabilities. The Company believes it has appropriately provided for income taxes for all years. Several factors drive the calculation of its tax reserves. Some of these factors include: (i) the expiration of various statutes of limitations; (ii) changes in tax law and regulations; (iii) issuance of tax rulings; and (iv) settlements with tax authorities. Changes in any of these factors may result in adjustments to the Company’s reserves, which would impact its reported financial results.

Other Income (Expense), Net

Other Income (Expense), Net	12 Months Ended
	Dec. 31, 2021
Other Income (Expense), Net [Abstract]
Other Income (Expense), Net	17. Other Income (Expense), Net Other income (expense), net of expense in 2021, 2020 and 2019, respectively. Other income (expense), net includes 2021, 2020 and 2019

Supplemental Cash Flow Informat

Supplemental Cash Flow Information	12 Months Ended
	Dec. 31, 2021
Supplemental Cash Flow Information [Abstract]
Supplemental Cash Flow Information	18. Supplemental Cash Flow Information Cash paid for interest totaled $8.6 million, $11.2 million and $17.9 million for the years ended December 31, 2021, 2020 and 2019 2021, 2020 and 2019

Acquisitions

Acquisitions	12 Months Ended
	Dec. 31, 2021
Acquisitions [Abstract]
Acquisitions	19. Acquisitions In December 2020, the Company acquired 100% of the outstanding equity interest of Ingredient Innovations International Company (“3i”). The purchase price for 3i was $15.7 million, net of cash acquired of $2.1 million and $0.8 million to be paid within six months, all payable in cash. In addition, there is potential for an incremental $7.0 million in contingent consideration, which becomes payable if certain performance targets are reached in 2021 and 2022. The fair value of the contingent consideration recorded on the acquisition date was $3.1 million. The Company allocated the gross purchase price of $24.5 million to the assets acquired and liabilities assumed at estimated fair values. The estimated fair value of assets acquired included $14.4 million of intangible assets, $0.3 million of property and equipment, $2.1 million of cash, $0.8 million of accounts receivable and less than $0.3 million of inventory, and the acquisition also included approximately $0.3 million of current liabilities and resulted in a deferred tax liability of $3.1 million. The excess purchase price over the aggregate fair value of assets acquired less liabilities assumed of $6.4 million was recorded as goodwill. The intangible assets acquired were comprised of $3.7 million for Customer relationships, $10.0 million for technology and $0.7 million for other intangibles, all with an assigned estimated useful life of approximately 8 years. All the goodwill was assigned to our Manufacturing segment. The allocation of the fair value of assets acquired and liabilities assumed for the acquisition was finalized during the three months ended March 31, 2021. In April 2021, the Company acquired 100% ownership in MyFavoriteThings, Inc. (“Mavely”) making Mavely a wholly owned subsidiary of the Company. The acquisition enables the Company to continue to expand its digital tools. The purchase price for Mavely was $16.8 million, net of cash acquired of $0.4 million and $0.9 million to be paid within six months, all payable in cash. In addition, there is potential for an incremental $24.0 million in contingent consideration, which becomes payable if certain revenue and profitability targets are reached in 2021, 2022 and 2023. The fair value of the contingent consideration recorded on the acquisition date was $8.7 million. The Company allocated the gross purchase price of $29.4 million to the assets acquired and liabilities assumed at estimated fair values. The estimated fair value of assets acquired included $16.4 million of intangible assets, $0.4 million of cash, $0.1 million of accounts receivable, and also resulted in a deferred tax liability of $3.5 million. The excess purchase price over the aggregate fair value of assets acquired less liabilities assumed of $12.6 million was recorded as goodwill. The goodwill recognized is attributable primarily to expected synergies. None of the goodwill is expected to be deductible for income tax purposes. The intangible assets acquired were comprised of $2.0 million for customer relationships, $11.3 million for technology, $2.8 million for trademarks and $0.3 million for other intangibles. The intangibles were assigned useful lives of 8 years for the technology and trademarks, approximately 4 years for the customer relationships and 3 years for the other intangibles. All the goodwill was assigned to our Rhyz other segment. The allocation of the fair value of assets acquired and liabilities assumed for the acquisition was finalized during the three months ended September 30, 2021.

Restructuring and Severance Cha

Restructuring and Severance Charges	12 Months Ended
	Dec. 31, 2021
Restructuring and Severance Charges [Abstract]
Restructuring and Severance Charges	20. Restructuring and Severance Charges In 2021, the Company determined to exit the Grow Tech segment, to better align its resources on key strategic initiatives to achieve the future growth objectives and priorities of the core Nu Skin business. The Grow Tech segment was pursuing the commercialization of controlled-environment agriculture for use in the agriculture feed industry. This segment has been operating as part of the Company’s Rhyz strategic investment arm. As a result of the restructuring program, the Company recorded a non-cash charge of $38.5 million in 2021 , including $9.2 million $9.0 million for impairment of , $13.7 million of asset impairments and $6.6 million for inventory write-off

Summary of Significant Accoun_2

Summary of Significant Accounting Policies (Policies)	12 Months Ended
	Dec. 31, 2021
Summary of Significant Accounting Policies [Abstract]
Consolidation	Consolidation The consolidated financial statements include the accounts of the Company and the Subsidiaries. All significant intercompany accounts and transactions are eliminated in consolidation.
Use of Estimates	Use of estimates The preparation of these financial statements, in conformity with accounting principles generally accepted in the United States of America (“U.S. GAAP”), required management to make estimates and assumptions that affected the reported
Cash and Cash Equivalents	Cash and cash equivalents Cash equivalents are short-term, highly liquid instruments with original maturities of 90 days or less.
Accounts Receivable	Accounts receivable Accounts receivable represents amounts owed to us through our operating activities and are presented net of allowance for doubtful accounts. Accounts receivable for core Nu Skin consists primarily of credit card receivables, while accounts receivable for our Rhyz investments consist primarily of trade receivables from customer sales. For the Company’s trade receivables from its Rhyz investment customers, the Company performs ongoing credit evaluations of its customers and maintains an allowance for expected credit losses. The allowance for expected credit losses represents the Company’s best estimate based on current and historical information, and reasonable and supportable forecasts of future events and circumstances.
Inventories	Inventories Inventories consist primarily of merchandise purchased for resale and are stated at the lower of standard cost or net realizable value, using a standard cost method which approximates the first-in, first-out method. The Company had reserves of its inventory carrying value totaling $ million and $ million as of December 31, 2021 and 2020, respectively. Inventories consist of the following (U.S. dollars in thousands): December 31, 2021 2020 Raw materials $ 179,891 $ 118,877 Finished goods 220,040 195,489 Total inventory, net $ 399,931 $ 314,366 Reserves of inventories consist of the following (U.S. dollars in thousands): 2021 2020 2019 Beginning balance $ 14,249 $ 12,295 $ 14,149 Additions 31,300 15,952 14,931 Write-offs (26,906 ) (13,998 ) (16,785 ) Ending balance $ 18,643 $ 14,249 $ 12,295
Property and Equipment	Property and equipment Property and equipment are stated at cost less accumulated depreciation. Depreciation is recorded using the straight-line method over the following estimated useful lives: Buildings 39 years Furniture and fixtures 5 - 7 years Computers and equipment 3 - 5 years Leasehold improvements Shorter of estimated useful life or lease term Scanners 3 years Vehicles 3 - 5 years Expenditures for maintenance and repairs are charged to expense as incurred. When an asset is sold or otherwise disposed of, the cost and associated accumulated depreciation are removed from the accounts and the resulting gain or loss is recognized in the statement of income. Property and equipment are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of such assets may not be recoverable. An impairment loss is recognized if the carrying amount of the asset exceeds its fair value.
Leases	Leases On January 1, 2019, the Company adopted Topic 842 using the modified retrospective method. The Company determines if an arrangement is a lease at inception. Operating leases are included in operating lease right-of-use (“ROU”) assets, accrued expenses and operating lease liabilities on the consolidated balance sheets. Finance leases are included in other assets, accrued expenses and other liabilities on the consolidated balance sheets. Operating lease ROU assets represent the Company’s right to use an underlying asset for the lease term, and lease liabilities represent the Company’s obligation to make lease payments arising from the lease. ROU assets and lease liabilities are recognized at the lease commencement date based on the estimated present value of lease payments over the lease term. The Company uses its estimated incremental borrowing rate based on the information available at commencement date in determining the present value of future payments. The operating lease ROU assets also include any lease payments made and exclude lease incentives and initial direct costs incurred. The Company’s lease terms may include options to extend or terminate the lease when it is reasonably certain that the Company will exercise that option. Lease expense for minimum lease payments is recognized on a straight-line basis over the lease term. Leases with a term of months or less are not recorded on the balance sheet. The Company’s lease agreements do not contain any residual value guarantees. The Company has lease agreements with lease and non-lease components. The Company accounts for the lease and non-lease components as a single lease component.
Goodwill and Other Intangible Assets	Goodwill and other intangible assets Goodwill is recorded when the cost of acquired businesses exceeds the fair value of the identifiable net assets acquired. Goodwill and intangible assets with indefinite useful lives are not amortized, but are assessed for impairment annually on October 1. In addition, impairment testing is conducted when events occur or circumstances change that would more likely than not reduce the fair value of a reporting unit below its carrying amount. Goodwill and intangible assets with indefinite useful lives would be written down to fair value if considered impaired. Guidance under Accounting Standards Codification (“ASC”) 350, Intangibles - Goodwill and Other In fiscal year 2020, a quantitative assessment was performed. fiscal years 2021 and 2019, The Company has historically evaluated its goodwill for impairment annually as of June 30 or more frequently if impairment indicators arose in accordance with Accounting Standards Codification (“ASC”) Topic 350, “Intangibles - Goodwill and Other.” In the fourth quarter of 2021, the Company changed the date of its annual assessment of goodwill to October 1 for all reporting units. The change in testing date for goodwill is a change in accounting principle, which management believes is preferable as the new date of the assessment better aligns with the Company’s budgeting process and will create a more efficient and timely process surrounding the impairment tests. The change in the assessment date does not delay, accelerate or avoid a potential impairment charge. The Company has determined that it is impracticable to objectively determine projected cash flows and related valuation estimates that would have been used as of each October 1 of prior reporting periods without the use of hindsight. As such, the Company prospectively applied the change in annual goodwill impairment testing date from October 1, 2021. No impairment was recognized during the years ended December 31, 2020 or 2019. As discussed further in Note 20 - Restructuring and Severance Charges, during the fourth quarter of fiscal year 2021, the Company recognized an $18.2 million goodwill and intangibles impairment charge related to the Grow Tech segment, which was included in Restructuring and impairment expenses in the consolidated statements of income.
Equity Investments	Equity Investments The Company holds strategic investments in other companies. These investments are accounted for under the measurement alternative described in ASC 321, Investments - Equity Securities
Revenue Recognition	Revenue recognition Net sales include products and shipping and handling charges, net of estimates for product returns and any related sales incentives. Revenue is measured as the amount of consideration we expect to receive in exchange for transferring products. All revenue is recognized when we satisfy our performance obligations under the contract. The Company recognizes revenue by transferring the promised products to the customer, with revenue recognized at shipping point, the point in time the customer obtains control of the products. The Company recognizes revenue for shipping and handling charges at the time the products are delivered to or picked up by the customer. A reserve for product returns is accrued based on historical experience totaling $3.5 million and $4.0 million as of December 31, 2021 and 2020, respectively. During the years ended December 31, 2021, 2020 and 2019, the Company recorded sales returns of $52.1 million, $49.5 million and $52.2 million, respectively. The majority of the Company’s contracts have a single performance obligation and are short term in nature. Sales taxes and value added taxes in foreign jurisdictions that are collected from customers and remitted to governmental authorities are accounted for on a net basis and therefore are excluded from net sales. Contract Liabilities – Customer Loyalty Programs Contract liabilities, recorded as deferred revenue within the accrued expenses line in the consolidated balance sheets, include loyalty point program deferrals with certain customers which are accounted for as a reduction in the transaction price and are generally recognized as points are redeemed for additional products. The balance of deferred revenue related to contract liabilities was $22.0 million and $18.2 million as of December 31, 2021, and 2020, respectively. The contract liabilities impact to revenue for the years ended December 31, 2021, 2020 and 2019 was a decrease of $3.8 million, a decrease of $5.7 million and an increase of $1.3 million, respectively. Disaggregation of Revenue Please refer to Note 15 - Segment Information for revenue by segment and product line. Arrangements with Multiple Performance Obligations The Company’s contracts with customers may include multiple performance obligations. For such arrangements, the Company allocates revenues to each performance obligation based on its relative standalone selling price. The Company generally determines standalone selling prices based on the prices charged to customers for individual products sales to customers.
Shipping and Handling Costs	Shipping and handling costs Shipping and handling costs are recorded as cost of sales and are expensed as incurred.
Advertising Expenses	Advertising expenses Advertising costs are expensed as incurred and are included in general and administrative expenses in the accompanying consolidated statements of income.
Selling Expenses	Selling expenses Selling expenses are the Company’s most significant expense and are classified as operating expenses. Selling expenses include commissions the Company pays to its Brand Affiliates, as well as salaries, service fees, benefits, bonuses and other labor and unemployment expenses the Company pays to its sales force in Mainland China. Selling expenses do not include amounts the Company pays to its sales force based on their personal purchases; rather, such amounts are reflected as reductions to revenue.The term “Brand Affiliates” refers to members of the Company’s independent sales force in all of the Company’s markets besides Mainland China. In each of the Company’s markets, except Mainland China, Sales Leaders can earn “multi-level” compensation under the Company’s global sales compensation plan, including commissions for product sales to their consumer groups as well as the product sales made through the sales network they have developed and trained. The Company does not pay commissions on sales materials. Outside of Mainland China, the Company’s Brand Affiliates may make profits by purchasing the products from the Company at a discount and selling them to consumers with a mark-up. The Company does not account for nor pay additional commissions on these mark-ups received by Brand Affiliates. In many markets, the Company also allows individuals who are not members of its sales force, referred to as “preferred customers,” to buy products directly from the Company at a discount. The Company pays commissions on preferred customer purchases to the referring member of its sales force.
Research and Development	Research and development Research and development costs are expensed as incurred and are included in general and administrative expenses in the accompanying consolidated statements of income and totaled $27.2 million, $23.3 million and $30.1 million in 2021, 2020 and 2019, respectively.
Deferred Tax Assets and Liabilities	Deferred tax assets and liabilities The Company accounts for income taxes in accordance with the Income Taxes Topic of the Financial Accounting Standards Codification. These standards establish financial accounting and reporting standards for the effects of income taxes that result from an enterprise’s activities during the current and preceding years. The Company takes an asset and liability approach for financial accounting and reporting of income taxes. The Company pays income taxes in many foreign jurisdictions based on the profits realized in those jurisdictions, which can be significantly impacted by terms of intercompany transactions between the Company and its foreign affiliates. Deferred tax assets and liabilities are created in this process. The Company has netted these deferred tax assets and deferred tax liabilities by jurisdiction. These deferred tax assets assume sufficient future earnings will exist for their realization, and are calculated using anticipated tax rates. Valuation allowances are established when necessary to reduce deferred tax assets to the amounts expected to be ultimately realized.
Uncertain Tax Positions	Uncertain tax positions The Company files income tax returns in the U.S. federal jurisdiction, and in various state and foreign jurisdictions. In 2009, we entered into a voluntary program with the IRS called Compliance Assurance Process (“CAP”). Under the CAP program, the IRS audits the tax position of the identify and resolve any tax issues that may arise throughout the tax year. As of December 31, 2021, tax through 2020 audited and are effectively closed to further examination. For tax years 2021 and 2022, the Company is in the Bridge phase of the CAP program, pursuant to which the IRS will not accept disclosures, will not conduct reviews and will not provide letters of assurance for the year. There are limited circumstances that tax years in the Bridge phase will be opened for examination. we are 2018 2015 A reconciliation of the beginning and ending amount of unrecognized tax benefits included in other liabilities is as follows (U.S. dollars in thousands): 2021 2020 2019 Gross balance at January 1 $ 17,620 $ 13,507 $ 11,456 Increases related to prior year tax positions 4,146 2,958 775 Increases related to current year tax positions 1,794 3,302 2,273 Settlements (5,494 ) (1,091 ) — Decreases due to lapse of statutes of limitations (2,409 ) (1,377 ) (1,051 ) Currency adjustments (567 ) 321 54 Gross balance at December 31 $ 15,090 $ 17,620 $ 13,507 At December 31, 2021, the Company had $ million in unrecognized tax benefits of which $ million, if recognized, would affect the effective tax rate. In comparison, at 17.6 million in unrecognized tax benefits of which $ million, if recognized, would affect the effective tax rate. T Company’s gross unrecognized During the years ended December 31, 2021, and 2021, 2019, respectively.
Net Income per Share	Net income per share Net income per share is computed based on the weighted-average number of common shares outstanding during the periods presented. Additionally, diluted earnings per share data gives effect to all potentially dilutive common shares that were outstanding during the periods presented (Note 8).
Foreign Currency Translation and Classification of a Highly Inflationary Economy	Foreign currency translation A significant portion of the Company’s business operations occurs outside of the United States. The local currency of each of the Company’s Subsidiaries is considered its functional currency, except for the Company’s subsidiaries in Singapore and countries deemed highly inflationary where the U.S. dollar is used. All assets and liabilities are translated into U.S. dollars at exchange rates existing at the balance sheet dates, revenue and expenses are translated at weighted-average exchange rates and stockholders’ equity is recorded at historical exchange rates. The resulting foreign currency translation adjustments are recorded as a separate component of stockholders’ equity in the consolidated balance sheets and transaction gains and losses are included in other income (expense) in the consolidated statements of income Classification of a highly inflationary economy A market is considered to have a highly inflationary economy if it has a cumulative inflation rate of approximately 100% or more over a three-year period as well as other qualitative factors including historic inflation rate trends (increasing and decreasing), the capital intensiveness of the operation and other pertinent economic factors. The functional currency in highly inflationary economies is required to be the functional currency of the entity’s parent company, and transactions denominated in the local currency are remeasured to the functional currency. The remeasurement of local currency into U.S. dollars creates foreign currency transaction gains or losses, which the Company includes in its consolidated statements of income. In the second quarter of 2018, published inflation indices indicated that the three-year cumulative inflation in Argentina exceeded 100 percent, and as of July 1, 2018, we elected to adopt highly inflationary accounting for our subsidiary in Argentina. Under highly inflationary accounting, Argentina’s functional currency became the U.S. dollar, and its income statement and balance sheet have been measured in U.S. dollars using both current and historical rates of exchange. The effect of changes in exchange rates on peso-denominated monetary assets and liabilities has been reflected in earnings in Other income (expense), net and was not material. As of December 31, 2021, and 2020, Argentina had a small net peso monetary position. Net sales of Argentina were less than of our consolidated net sales for the year ended December 31, 2021, 2020 and 2019.
Fair Value of Financial Instruments	Fair value of financial instruments The carrying value of financial instruments including cash and cash equivalents, accounts receivable and accounts payable approximate fair values due to the short-term nature of these instruments. The Company’s current investments as of December 31, 2021 include certificates of deposits and pre-refunded municipal bonds that are classified by management as held-to-maturity as the Company had the positive intent and ability to hold to maturity. The carrying value of these current investments approximate fair values due to the short-term nature of these instruments. As of December 31, 2021 and 2020, the fair value of debt was $377.5 million and $337.5 million, respectively. The estimated fair value of the Company’s debt is based on interest rates available for debt with similar terms and remaining maturities. The FASB Codification defines fair value as the price that would be received to sell an asset or paid to transfer a liability in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants at the measurement date. On a quarterly basis, the Company measures at fair value certain financial assets, including cash equivalents. Accounting standards specify a hierarchy of valuation techniques based on whether the inputs to those valuation techniques are observable or unobservable. Observable inputs reflect data obtained from independent sources, while unobservable inputs reflect the Company’s market assumptions. These two types of inputs have created the following fair-value hierarchy: ● Level 1 – quoted prices in active markets for identical assets or liabilities; ● Level 2 – inputs, other than the quoted prices in active markets, that are observable either directly or indirectly; ● Level 3 – unobservable inputs based on the Company’s own assumptions. Accounting standards permit companies, at their option, to measure many financial instruments and certain other items at fair value. The Company has elected not to apply the fair value option to existing eligible items.
Stock-based Compensation	Stock-based compensation All share-based payments, including grants of stock options and restricted stock units, are required to be recognized in the Company’s financial statements based upon their respective grant date fair values. The Black-Scholes option-pricing model is used to estimate the fair value of stock options. The determination of the fair value of stock options is affected by the Company’s stock price and a number of assumptions, including expected volatility, expected life, risk-free interest rate and expected dividends. The Company uses historical volatility as the expected volatility assumption required in the Black-Scholes model. The expected life of the stock options is based on historical data trended into the future. The risk-free interest rate assumption is based on observed interest rates appropriate for the expected terms of the Company’s stock options. The fair value of the Company’s restricted stock units is based on the closing market price of its stock on the date of grant less the Company’s expected dividend yield. The Company recognizes stock-based compensation net of actual forfeitures over the requisite service period of the award. The total compensation expense related to equity compensation plans was $23.2 million, $24.1 million and $9.9 million for the years ended December 31, 2021, 2020 and 2019, respectively. In 2021, 2020 and 2019, these amounts reflect the reversal of , , and $ million, respectively, for certain performance-based awards that were no longer expected to vest. For the years ended December 31, 2021, 2020 and 2019, all stock-based compensation expense was recorded within general and administrative expenses.
Reporting Comprehensive Income	Reporting comprehensive income Comprehensive income is defined as the change in equity of a business enterprise during a period from transactions and other events and circumstances from non-owner sources, and it includes all changes in equity during a period except those resulting from investments by owners and distributions to owners.
Derivative Instruments and Hedging Activities	Derivative instruments and hedging activities FASB ASC 815, Derivatives and Hedging As required by ASC 815, the Company records all derivatives on the balance sheet at fair value. The accounting for changes in the fair value of derivatives depends on the intended use of the derivative, whether the Company has elected to designate a derivative in a hedging relationship and apply hedge accounting and whether the hedging relationship has satisfied the criteria necessary to apply hedge accounting. Derivatives designated and qualifying as a hedge of the exposure to changes in the fair value of an asset, liability, or firm commitment attributable to a particular risk, such as interest rate risk, are considered fair value hedges. Derivatives designated and qualifying as a hedge of the exposure to variability in expected future cash flows, or other types of forecasted transactions, are considered cash flow hedges. Derivatives may also be designated as hedges of the foreign currency exposure of a net investment in a foreign operation. Hedge accounting generally provides for the matching of the timing of gain or loss recognition on the hedging instrument with the recognition of the changes in the fair value of the hedged asset or liability that are attributable to the hedged risk in a fair value hedge or the earnings effect of the hedged forecasted transactions in a cash flow hedge. The Company may enter into derivative contracts that are intended to economically hedge certain of its risk, even though hedge accounting does not apply or the Company elects not to apply hedge accounting. In accordance with the FASB’s fair value measurement guidance in ASU 2011-04, the Company made an accounting policy election to measure the credit risk of its derivative financial instruments that are subject to master netting agreements on a net basis by counterparty portfolio.
Recent Accounting Pronouncements	Recent accounting pronouncements In March 2020, the FASB issued, ASU 2020-04, Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting

Summary of Significant Accoun_3

Summary of Significant Accounting Policies (Tables)	12 Months Ended
	Dec. 31, 2021
Summary of Significant Accounting Policies [Abstract]
Inventories	Inventories consist of the following (U.S. dollars in thousands): December 31, 2021 2020 Raw materials $ 179,891 $ 118,877 Finished goods 220,040 195,489 Total inventory, net $ 399,931 $ 314,366
Inventory Reserves	Reserves of inventories consist of the following (U.S. dollars in thousands): 2021 2020 2019 Beginning balance $ 14,249 $ 12,295 $ 14,149 Additions 31,300 15,952 14,931 Write-offs (26,906 ) (13,998 ) (16,785 ) Ending balance $ 18,643 $ 14,249 $ 12,295
Prepaid Expenses and Other	Prepaid expenses and other consist of the following (U.S. dollars in thousands): December 31, 2021 2020 Deferred charges $ 14,266 $ 10,540 Prepaid income tax 2,784 — Prepaid inventory and import costs 6,087 4,123 Prepaid rent, insurance and other occupancy costs 3,690 9,182 Prepaid promotion and event cost 4,382 10,002 Prepaid other taxes 9,333 10,565 Prepaid software license 17,041 9,107 Deposits 1,158 33,312 Other 18,165 14,732 Total prepaid expense and other $ 76,906 $ 101,563
Estimated Useful Lives	Property and equipment are stated at cost less accumulated depreciation. Depreciation is recorded using the straight-line method over the following estimated useful lives: Buildings 39 years Furniture and fixtures 5 - 7 years Computers and equipment 3 - 5 years Leasehold improvements Shorter of estimated useful life or lease term Scanners 3 years Vehicles 3 - 5 years
Other Assets	Other assets consist of the following (U.S. dollars in thousands): December 31, 2021 2020 Deferred taxes $ 26,483 $ 35,414 Deposits for noncancelable operating leases 17,121 20,783 Cash surrender value for life insurance policies 49,851 45,453 Right-of-use assets, Financing, net 6,477 9,385 Long-term investments 35,868 11,344 Other 39,660 15,703 Total other assets $ 175,460 $ 138,082
Accrued Expenses	Accrued expenses consist of the following (U.S. dollars in thousands): December 31, 2021 2020 Accrued sales force commissions and other payments $ 139,793 $ 149,481 Accrued income taxes — 13,921 Accrued other taxes 31,135 45,018 Accrued payroll and other employee expenses 53,641 65,272 Accrued payable to vendors 45,347 47,201 Short-term operating lease liability 33,427 44,981 Accrued royalties 1,095 1,008 Sales return reserve 3,513 3,978 Deferred revenue 33,139 35,054 Other 31,111 40,768 Total accrued expenses $ 372,201 $ 446,682
Other Liabilities	Other liabilities consist of the following (U.S. dollars in thousands): December 31, 2021 2020 Deferred tax liabilities $ 2,385 $ 626 Reserve for other tax liabilities 21,774 22,731 Liability for deferred compensation plan 54,213 47,543 Contingent consideration 10,341 3,125 Finance lease liabilities 5,318 7,728 Asset retirement obligation 5,408 6,717 Other 7,035 13,811 Total other liabilities $ 106,474 $ 102,281
Unrecognized Tax Benefits	A reconciliation of the beginning and ending amount of unrecognized tax benefits included in other liabilities is as follows (U.S. dollars in thousands): 2021 2020 2019 Gross balance at January 1 $ 17,620 $ 13,507 $ 11,456 Increases related to prior year tax positions 4,146 2,958 775 Increases related to current year tax positions 1,794 3,302 2,273 Settlements (5,494 ) (1,091 ) — Decreases due to lapse of statutes of limitations (2,409 ) (1,377 ) (1,051 ) Currency adjustments (567 ) 321 54 Gross balance at December 31 $ 15,090 $ 17,620 $ 13,507

Property and Equipment (Tables)

Property and Equipment (Tables)	12 Months Ended
	Dec. 31, 2021
Property and Equipment [Abstract]
Property and Equipment	Property and equipment are comprised of the following (U.S. dollars in thousands): December 31, 2021 2020 Land $ 45,027 $ 45,242 Buildings 281,192 278,779 Construction in progress (1) 44,021 34,954 Furniture and fixtures 147,786 146,413 Computers and equipment 162,746 137,914 Leasehold improvements 129,675 164,963 Scanners 6,746 8,119 Vehicles 2,021 2,112 819,214 818,496 Less: accumulated depreciation (365,540 ) (350,315 ) $ 453,674 $ 468,181 (1) Construction in progress includes $11.0 million and $13.6 million as of December 31, 2021 and 2020, respectively, of eligible capitalized internal-use software development costs which will be reclassified to computers and equipment when placed into service.

Goodwill (Tables)

Goodwill (Tables)	12 Months Ended
	Dec. 31, 2021
Goodwill [Abstract]
Goodwill	The following table presents goodwill allocated to the Company’s reportable segments for the periods ended December 31, 2021 and 2020 (U.S. dollars in thousands): December 2021 2020 Nu Skin Mainland China $ 32,179 $ 32,179 Americas 9,449 9,449 South Korea 29,261 29,261 Southeast Asia/Pacific 18,537 18,537 EMEA 2,875 2,875 Japan 16,019 16,019 Hong Kong/Taiwan 6,634 6,634 Rhyz Investments Manufacturing 78,875 78,875 Grow Tech — 9,150 Rhyz Other 12,603 — Total $ 206,432 $ 202,979

Other Intangible Assets (Tables

Other Intangible Assets (Tables)	12 Months Ended
	Dec. 31, 2021
Other Intangible Assets [Abstract]
Indefinite Life Intangible Assets	Other intangible assets consist of the following (U.S. dollars in thousands): Carrying Amount at December 31, 2021 2020 Indefinite life intangible assets: Trademarks and trade names $ 24,599 $ 24,599 Other indefinite lived intangibles — 3,763 $ 24,599 $ 28,362
Finite Life Intangible Assets	December 31, 2021 December 31, 2020 Finite life intangible assets: Gross Carrying Amount Accumulated Amortization Gross Carrying Amount Accumulated Amortization Weighted- average Amortization Period Scanner technology $ 40,716 $ 40,716 $ 40,716 $ 40,716 18 years Developed technology 43,841 24,697 32,546 21,680 14 years Sales force network 11,598 11,598 11,598 11,598 15 years Trademarks 8,989 3,827 6,145 2,938 10 years Other 51,176 23,090 71,095 23,998 10 years $ 156,320 $ 103,928 $ 162,100 $ 100,930 14 years
Future Amortization Expense	The estimated annual amortization expense for each of the five succeeding fiscal years are as follows (U.S. dollars in thousands): Year Ending December 31, 2022 $ 9,282 2023 9,135 2024 8,625 2025 7,502 2026 7,135

Long-Term Debt (Tables)

Long-Term Debt (Tables)	12 Months Ended
	Dec. 31, 2021
Long-Term Debt [Abstract]
Debt Facilities	The following table summarizes the Company’s debt facilities as of December 31, 2021 and 2020: Facility or Arrangement Original Principal Amount Balance as of December 31, 2021 (1)(2 ) Balance as of December 31, 2020 (1)(2) Interest Rate Repayment Terms Credit Agreement term loan facility $400.0 million $307.5 million $337.5 million Variable 35% of the principal amount is payable Credit Agreement revolving credit facility $70.0 million — Variable Revolving line of credit expires April 18, 2023. (1) As of December 31, 2021 and 2020, the current portion of the Company’s debt (i.e. becoming due in the next 12 months) included $37.5 million and $30.0 million, respectively, of the balance of its term loan under the Credit Agreement. (2) The carrying value of the debt reflects the amounts stated in the above table, less debt issuance costs of $1.2 million and $2.1 million as of December 31, 2021 and 2020, respectively, related to the Credit Agreement, which are not reflected in this table.
Maturities of Long-Term Debt	Maturities of all long-term debt at December 31, 2021, are as follows (U.S. dollars in thousands): Year Ending December 31, 2022 $ 37,500 2023 270,000 2024 — 2025 — 2026 — Thereafter — Total (1) $ 307,500 (1) The carrying value of the debt reflects the amounts stated in the above table less debt issuance costs of $1.2 million, which is not reflected in this table.

Leases (Tables)

Leases (Tables)	12 Months Ended
	Dec. 31, 2021
Leases [Abstract]
Components of Lease Expense	The components of lease expense were as follows (U.S. dollars in thousands): Year Ended December 31, 2021 2020 2019 Operating lease expense Operating lease cost $ 48,447 $ 51,828 $ 51,072 Variable lease cost 5,734 4,366 3,387 Short-term lease cost 592 1,056 169 Sublease income (5,663 ) (5,052 ) (5,743 ) Finance lease expense Amortization of right-of-use assets 2,398 1,023 — Interest on lease liabilities 319 154 — Total lease expense $ 51,827 $ 53,375 $ 48,885
Supplemental Cash Flow Information Related to Leases	Supplemental cash flow information related to leases was as follows (U.S. dollars in thousands): Year Ended December 31, 2021 2020 2019 Operating cash outflow from operating leases $ 51,570 $ 56,395 $ 54,993 Operating cash outflow from finance leases $ 322 $ 138 $ — Financing cash outflow from finance leases $ 1,871 $ 709 $ — Right-of-use assets obtained in exchange for operating lease obligations $ 25,427 $ 82,662 $ 184,502 Right-of-use assets obtained in exchange for finance lease obligations $ 74 $ 9,206 $ —
Maturities of Lease Liabilities	Maturities of lease liabilities were as follows (U.S. dollars in thousands): Year Ending December 31, Operating Leases Finance Leases 2022 $ 35,960 $ 2,152 2023 24,806 2,064 2024 19,254 1,954 2025 14,336 1,381 2026 7,341 260 Thereafter 36,612 — Total 138,309 7,811 Less: Finance charges 17,658 548 Total principal liability $ 120,651 $ 7,263

Capital Stock (Tables)

Capital Stock (Tables)	12 Months Ended
	Dec. 31, 2021
Capital Stock [Abstract]
Weighted Average Common Shares Outstanding	The following is a reconciliation of the weighted-average common shares outstanding for purposes of computing basic and diluted net income per share (in thousands): Year Ended December 31, 2021 2020 2019 Basic weighted-average common shares outstanding 50,193 52,296 55,518 Effect of dilutive securities: Stock awards and options 1,234 469 409 Diluted weighted-average common shares outstanding 51,427 52,765 55,927

Stock-Based Compensation (Table

Stock-Based Compensation (Tables)	12 Months Ended
	Dec. 31, 2021
Stock-Based Compensation [Abstract]
Stock Option Valuation Assumptions	The fair value of stock option awards was estimated using the Black-Scholes option-pricing model with the following assumptions and weighted-average fair values as follows: December 31, Stock Options: 2021 2020 2019 Weighted-average grant date fair value of grants $ 16.10 $ 8.59 $ 19.72 Risk-free interest rate (1) 0.5 % 1.4 % 2.5 % Dividend yield (2) 2.9 % 2.9 % 2.7 % Expected volatility (3) 49.5 % 40.7 % 42.4 % Expected life in months (4) 56 months 59 months 60 months (1) The risk-free interest rate is based upon the rate on a zero-coupon U.S. Treasury bill, for periods within the contractual life of the option, in effect at the time of the grant. (2) The dividend yield is based on the average of historical stock prices and actual dividends paid. (3) Expected volatility is based on the historical volatility of the Company’s stock price, over a period similar to the expected life of the option. (4) The expected term of the option is based on the historical employee exercise behavior, the vesting terms of the respective option, and a contractual life of either seven or .
Stock Options	Options under the plans as of December 31, 2021 and changes during the year ended December 31, 2021 were as follows: Shares (in thousands) Weighted- average Exercise Price Weighted- average Remaining Contractual Term Aggregate Intrinsic Value (in thousands) Options activity – service based Outstanding at December 31, 2020 770.6 $ 38.71 Granted — — Exercised (188.8 ) 37.74 Forfeited/cancelled/expired (43.6 ) 77.71 Outstanding at December 31, 2021 538.2 35.89 1.15 $ 8,303 Exercisable at December 31, 2021 538.2 35.89 1.15 8,303 Options activity – performance based Outstanding at December 31, 2020 2,398.0 $ 46.71 Granted 877.9 41.68 Exercised (297.6 ) 32.00 Forfeited/cancelled/expired (758.2 ) 63.77 Outstanding at December 31, 2021 2,220.1 40.87 4.62 $ 27,353 Exercisable at December 31, 2021 974.6 40.39 3.59 13,361 Options activity – all options Outstanding at December 31, 2020 3,168.6 $ 44.76 Granted 877.9 41.68 Exercised (486.4 ) 34.23 Forfeited/cancelled/expired (801.8 ) 64.53 Outstanding at December 31, 2021 2,758.3 39.90 3.95 $ 35,657 Exercisable at December 31, 2021 1,512.8 38.79 2.72 21,665
Stock Options Exercised	Cash proceeds, tax benefits and intrinsic value related to total stock options exercised during 2021, 2020 and 2019, were as follows (U.S. dollars in thousands): December 31, 2021 2020 2019 Cash proceeds from stock options exercised $ 14,435 $ 7,419 $ 368 Tax (expense) / benefit realized for stock options exercised 807 (459 ) 430 Intrinsic value of stock options exercised 8,402 5,232 934
Nonvested Restricted Stock Awards	Nonvested restricted stock awards as of December 31, 2021 and changes during the year ended December 31, 2021 were as follows: Number of Shares (in thousands) Weighted-average Grant Date Fair Value Nonvested at December 31, 2020 931.1 $ 46.38 Granted 380.4 50.39 Vested (307.6 ) 48.59 Forfeited (119.0 ) 45.95 Nonvested at December 31, 2021 884.9 $ 47.39

Fair Value and Equity Investm_2

Fair Value and Equity Investments (Tables)	12 Months Ended
	Dec. 31, 2021
Fair Value and Equity Investments [Abstract]
Assets (Liabilities) Measured at Fair Value on a Recurring Basis	The following tables present the fair value hierarchy for those assets and liabilities measured at fair value on a recurring basis (U.S. dollars in thousands): Fair Value at December 31, 2021 Level 1 Level 2 Level 3 Total Financial assets (liabilities): Cash equivalents and current investments $ 66,477 $ — $ — $ 66,477 Derivative financial instruments asset — 6,590 — 6,590 Life insurance contracts — — 49,851 49,851 Contingent consideration — — (10,341 ) (10,341 ) Total $ 66,477 $ 6,590 $ 39,510 $ 112,577 Fair Value at December 31, 2020 Level 1 Level 2 Level 3 Total Financial assets (liabilities): Cash equivalents and current investments $ 56,628 $ — $ — $ 56,628 Derivative financial instruments asset — 1,145 — 1,145 Life insurance contracts — — 45,453 45,453 Derivative financial instruments liability — (105 ) — (105 ) Contingent consideration — — (3,125 ) (3,125 ) Total $ 56,628 $ 1,040 $ 42,328 $ 99,996
Changes in Fair Value of Level 3 Life Insurance Contracts	The following table provides a summary of changes in fair value of the Company’s Level 3 life insurance contracts (U.S. dollars in thousands): 2021 2020 Beginning balance at January 1 $ 45,453 $ 41,707 Actual return on plan assets 5,153 3,746 Purchases and issuances 6,261 — Sales and settlements (7,016 ) — Transfers into Level 3 — — Ending balance at December 31 $ 49,851 $ 45,453
Changes in Fair Value of Level 3 Contingent Consideration	The following table provides a summary of changes in fair value of the Company’s Level 3 contingent consideration (U.S. dollars in thousands): 2021 2020 Beginning balance at January 1 $ (3,125 ) $ — Additions from acquisitions (8,702 ) (3,125 ) Changes in fair value of contingent consideration 1,486 — Ending balance at December 31 $ (10,341 ) $ (3,125 )

Income Taxes (Tables)

Income Taxes (Tables)	12 Months Ended
	Dec. 31, 2021
Income Taxes [Abstract]
Consolidated Income Before Provision for Income Taxes	Consolidated income before provision for income taxes consists of the following for the years ended December 31, 2021, 2020 and 2019 (U.S. dollars in thousands): 2021 2020 2019 U.S. $ 45,371 $ 71,138 $ 24,211 Foreign 187,088 185,094 230,961 Total $ 232,459 $ 256,232 $ 255,172
Current and Deferred Taxes	The provision for current and deferred taxes for the years ended December 31, 2021, 2020 and 2019 consists of the following (U.S. dollars in thousands): 2021 2020 2019 Current Federal $ — $ — $ — State 1,458 1,629 2,213 Foreign 77,393 77,079 79,694 78,851 78,708 81,907 Deferred Federal 3,705 (14,430 ) (8,878 ) State (38 ) (563 ) (473 ) Foreign 2,675 1,162 9,063 6,342 (13,831 ) (288 ) Provision for income taxes $ 85,193 $ 64,877 $ 81,619
Deferred Tax Assets and Liabilities	The principal components of deferred taxes are as follows (U.S. dollars in thousands): Year Ended December 31, 2021 2020 Deferred tax assets: Inventory differences $ 5,859 $ 6,181 Foreign tax credit and other foreign benefits 69,401 57,720 Stock-based compensation 9,392 8,925 Accrued expenses not deductible until paid 36,401 42,694 Foreign currency exchange 605 1,403 Net operating losses 9,479 8,667 Capitalized research and development 22,962 23,019 R&D credit carryforward 1,451 1,229 Other 34 45 Gross deferred tax assets 155,584 149,883 Deferred tax liabilities: Foreign withholding taxes 15,412 20,207 Intangibles step-up 4,446 4,623 Overhead allocation to inventory 3,373 2,684 Amortization of intangibles 21,936 18,551 Other 6,133 1,690 Gross deferred tax liabilities 51,300 47,755 Valuation allowance (80,186 ) (67,340 ) Deferred taxes, net $ 24,098 $ 34,788
Deferred Tax Asset Valuation Adjustments	The deferred tax asset valuation adjustments for the years ended December 31, 2021, 2020 and 2019 are as follows (U.S. dollars in thousands): Year Ended December 31, 2021 2020 2019 Balance at the beginning of period $ 67,340 $ 77,042 $ 68,697 Additions charged to cost and expenses 12,674 (1) 2,154 (4) 10,913 (6) Decreases — (2) (12,100 ) (5) (3,343 ) (7) Adjustments 172 (3) 244 (3) 775 (3) Balance at the end of the period $ 80,186 $ 67,340 $ 77,042 (1) Increase $11.9 million that was recorded on the foreign tax credit carryforward due to the disposal of the Companies Grow Tech segment. The additional amount is due to (2) No decreases in 2021. (3) Represents the net currency effects of translating valuation allowances at current rates of exchange. (4) Increase net operating losses in foreign markets . (5) The . (6) Increase in valuation is due primarily to $9.8 million that was recorded on the foreign tax credit carryforward. The additional amount is due to net operating losses in foreign markets. (7) The .
Deferred Taxes, Net on a Jurisdiction Basis	The components of deferred taxes, net on a jurisdiction basis are as follows (U.S. dollars in thousands): Year Ended December 31, 2021 2020 Net noncurrent deferred tax assets $ 26,483 $ 35,414 Net noncurrent deferred tax liabilities 2,385 626 Deferred taxes, net $ 24,098 $ 34,788
Reconciliation of Statutory to Effective Tax Rate	The actual tax rate for the years ended December 31, 2021, 2020 and 2019 compared to the statutory U.S. Federal tax rate is as follows: Year Ended December 31, 2021 2020 2019 Income taxes at statutory rate 21.00 % 21.00 % 21.00 % Excess tax benefit from equity award (0.19 )% 0.70 % 0.02 % Non-U.S. income taxed at different rates 6.06 % 3.37 % 3.09 % Foreign withholding taxes 4.71 % 5.21 % 4.10 % Change in reserve for uncertain tax positions (0.06 )% 1.98 % 1.07 % Valuation allowance recognized foreign tax credit & others 5.12 % (4.59 )% 2.56 % Foreign-Derived Intangible Income (FDII) (0.87 )% (2.78 )% (0.70 )% Other 0.88 % 0.43 % 0.85 % 36.65 % 25.32 % 31.99 %

Derivative Financial Instrume_2

Derivative Financial Instruments (Tables)	12 Months Ended
	Dec. 31, 2021
Derivative Financial Instruments [Abstract]
Fair Values of Derivative Instruments on the Balance Sheet	The table below presents the fair value of the Company’s derivative financial instruments as well as their classification on the Balance Sheet: Fair Values of Derivative Instruments December 31, Derivatives in Cash Flow Hedging Relationships: Balance Sheet Location 2021 2020 Interest Rate Swap - Asset Prepaid expenses and other $ 557 $ — Interest Rate Swap - Asset Other assets $ 6,033 $ 1,145 Interest Rate Swap - Liability Accrued expenses $ — $ 104
Effect of Cash Flow Hedge Accounting on Accumulated Other Comprehensive Income	The tables below present the effect of cash flow hedge accounting on Accumulated Other Comprehensive Income. Amount of Gain (Loss) Recognized in OCI on Derivative Year Ended December 31, Derivatives in Cash Flow Hedging Instruments: 2021 2020 2019 Interest Rate Swaps $ 5,391 $ 1,017 $ — Amount of Gain (Loss) Reclassified from Accumulated Other Comprehensive Loss into Income Year Ended December 31, Derivatives Designated as Hedging Instruments: Income Statement 2021 2020 2019 Interest Rate Swaps Other income/(expense) $ (157 ) $ (24 ) $ —

Segment Information (Tables)

Segment Information (Tables)	12 Months Ended
	Dec. 31, 2021
Segment Information [Abstract]
Revenue by Segment	Revenue by Segment Year Ended December 31, (U.S. dollars in thousands) 2021 2020 2019 Nu Skin Mainland China $ 568,774 $ 625,538 $ 722,526 Americas 547,755 453,022 304,422 South Korea 354,252 326,478 329,978 Southeast Asia/Pacific 336,651 361,627 346,276 EMEA 283,200 230,246 167,165 Japan 266,216 273,681 260,039 Hong Kong/Taiwan 162,611 161,117 166,335 Nu Skin Other 1,549 (17 ) 1,621 Total Nu Skin 2,521,008 2,431,692 2,298,362 Rhyz Investments Manufacturing (1) 172,120 149,339 121,917 Grow Tech 2,104 903 137 Rhyz Other 437 — — Total Rhyz Investments 174,661 150,242 122,054 Total $ 2,695,669 $ 2,581,934 $ 2,420,416 (1) The Manufacturing segment had $84.5 million, $39.4 million and $25.7 million of intersegment revenue for the years ended December 31, 2021, 2020 and 2019, respectively. Intersegment revenue is eliminated in the consolidated financial statements and in the table above.
Segment Contribution	Segment Contribution Year Ended December 31, (U.S. dollars in thousands) 2021 2020 2019 Nu Skin Mainland China $ 151,645 $ 181,024 $ 191,570 Americas 116,265 86,386 52,135 South Korea 114,034 100,933 99,892 Southeast Asia/Pacific 81,779 87,753 90,666 EMEA 41,988 24,078 10,195 Japan 67,511 68,027 61,081 Hong Kong/Taiwan 37,330 33,466 33,569 Nu Skin contribution 610,552 573,039 539,108 Rhyz Investments Manufacturing 18,346 21,168 15,693 Grow Tech (83,907 ) (22,430 ) (19,509 ) Rhyz Other (1,813 ) — — Rhyz Investments contribution (67,374 ) (1,262 ) (3,816 ) Total segment contribution 543,178 571,777 535,292 Corporate and other (309,186 ) (314,213 ) (267,866 ) Operating income 233,992 257,564 267,426 Other income (expense) (1,533 ) (1,332 ) (12,254 ) Income before provision for income taxes $ 232,459 $ 256,232 $ 255,172
Depreciation and Amortization and Capital Expenditures	Depreciation and Amortization Year Ended December 31, (U.S. dollars in thousands) 2021 2020 2019 Nu Skin Mainland China $ 13,345 $ 11,056 $ 10,496 Americas 871 984 767 South Korea 3,279 3,620 5,093 Southeast Asia/Pacific 1,450 1,670 2,012 EMEA 1,106 1,017 1,260 Japan 906 1,876 3,866 Hong Kong/Taiwan 3,637 2,912 2,310 Total Nu Skin 24,594 23,135 25,804 Rhyz Investments Manufacturing 11,765 8,081 6,689 Grow Tech 4,888 5,092 4,008 Other Rhyz Investments 1,579 — — Total Rhyz Investments 18,232 13,173 10,697 Corporate and other 33,494 37,683 40,149 Total $ 76,320 $ 73,991 $ 76,650 Capital Expenditures Year Ended December 31, (U.S. dollars in thousands) 2021 2020 2019 Nu Skin Mainland China $ 24,382 $ 19,363 $ 14,814 Americas 714 1,061 1,283 South Korea 854 1,420 1,223 Southeast Asia/Pacific 1,330 2,197 816 EMEA 1,242 1,875 364 Japan 194 3,128 1,528 Hong Kong/Taiwan 736 708 3,203 Total Nu Skin 29,452 29,752 23,231 Rhyz Investments Manufacturing 14,022 14,366 6,595 Grow Tech 1,683 2,499 6,938 Other Rhyz Investments — — — Total Rhyz Investments 15,705 16,865 13,533 Corporate and other 23,458 17,206 29,303 Total $ 68,615 $ 63,823 $ 66,067
Revenue by Major Market	A major market is defined as one with total revenue greater than 10% of consolidated total revenue. Based on this criteria, the Company has identified four major markets: Mainland China, South Korea, United States, and Japan. There are approximately 45 other markets, each of which individually is less than 10%. Year Ended December 31, (U.S. dollars in thousands) 2021 2020 2019 Mainland China $ 568,774 $ 625,538 $ 722,526 South Korea 354,252 326,478 329,978 Japan 266,216 273,681 260,039 United States 540,253 425,155 324,727 All others 966,174 931,082 783,146 Total $ 2,695,669 $ 2,581,934 $ 2,420,416
Revenue by Product Line	Revenue by Product Line Year Ended December 31, (U.S. dollars in thousands) 2021 2020 2019 Beauty (1) $ 1,442,659 $ 1,491,803 $ 1,423,485 Wellness (1) 1,062,549 922,553 863,125 Other (2) 190,461 167,578 133,806 Total $ 2,695,669 $ 2,581,934 $ 2,420,416 (1) Includes sales of beauty and wellness products in the core Nu Skin business. The beauty category includes $658 million, $712 million, $618 million in sales of devices and related consumables for the years ended December 31, 2021, 2020 and 2019, respectively. (2) Other includes the external revenue from the Rhyz companies along with a limited number of other products and services, including household products and technology services.
Long-Lived Assets by Major Market	A major market is defined as a market with long-lived assets greater than 10% of consolidated long-lived assets and also includes the Company’s country of domicile (the United States). Long-lived assets in Mainland China consist primarily of property, plant and equipment related to manufacturing, distribution facilities and the Mainland China headquarters. Long-lived assets in the United States consist primarily of property, plant and equipment, including the Company’s corporate offices and distribution facilities. Long-lived assets by major market are set forth below for the periods ended December 31, 2021, 2020 and 2019: Year Ended December 31, (U.S. dollars in thousands) 2021 2020 2019 United States $ 335,020 $ 348,028 $ 354,410 Mainland China 149,124 152,312 136,845 South Korea 25,364 39,104 35,286 Japan 23,929 31,085 12,015 All others 47,687 62,141 59,374 Total $ 581,124 $ 632,670 $ 597,930

The Company (Details)

The Company (Details)	12 Months Ended
	Dec. 31, 2021Segment
The Company [Abstract]
Number of reportable segments	10
Number of geographic segments	7

Summary of Significant Accoun_4

Summary of Significant Accounting Policies, Inventories (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Inventories [Abstract]
Raw materials	$ 179,891	$ 118,877
Finished goods	220,040	195,489
Total Inventory, net	399,931	314,366
Inventory Valuation Reserve [Member]
Valuation Allowance [Roll Forward]
Beginning balance	14,249	12,295	$ 14,149
Additions	31,300	15,952	14,931
Write-offs	(26,906)	(13,998)	(16,785)
Ending balance	$ 18,643	$ 14,249	$ 12,295

Summary of Significant Accoun_5

Summary of Significant Accounting Policies, Prepaid Expenses and Other (Details) - USD ($) $ in Thousands	Dec. 31, 2021	Dec. 31, 2020
Prepaid Expenses and Other [Abstract]
Deferred charges	$ 14,266	$ 10,540
Prepaid income tax	2,784	0
Prepaid inventory and import costs	6,087	4,123
Prepaid rent, insurance and other occupancy costs	3,690	9,182
Prepaid promotion and event cost	4,382	10,002
Prepaid other taxes	9,333	10,565
Prepaid software license	17,041	9,107
Deposits	1,158	33,312
Other	18,165	14,732
Total prepaid expense and other	$ 76,906	$ 101,563

Summary of Significant Accoun_6

Summary of Significant Accounting Policies, Property and Equipment (Details)	12 Months Ended
	Dec. 31, 2021
Buildings [Member]
Property and Equipment [Abstract]
Useful life	39 years
Furniture and Fixtures [Member] | Minimum [Member]
Property and Equipment [Abstract]
Useful life	5 years
Furniture and Fixtures [Member] | Maximum [Member]
Property and Equipment [Abstract]
Useful life	7 years
Computers and Equipment [Member] | Minimum [Member]
Property and Equipment [Abstract]
Useful life	3 years
Computers and Equipment [Member] | Maximum [Member]
Property and Equipment [Abstract]
Useful life	5 years
Leasehold Improvements [Member]
Property and Equipment [Abstract]
Useful life	Shorter of estimated useful life or lease term
Scanners [Member]
Property and Equipment [Abstract]
Useful life	3 years
Vehicles [Member] | Minimum [Member]
Property and Equipment [Abstract]
Useful life	3 years
Vehicles [Member] | Maximum [Member]
Property and Equipment [Abstract]
Useful life	5 years

Summary of Significant Accoun_7

Summary of Significant Accounting Policies, Goodwill and Other Intangible Assets (Details) - USD ($) $ in Millions	3 Months Ended	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Goodwill and Other Intangible Assets [Abstract]
Impairment charges		$ 0	$ 0
Grow Tech Segment [Member] | Restructuring and Impairment Expenses [Member]
Goodwill and Other Intangible Assets [Abstract]
Impairment charges	$ 18.2

Summary of Significant Accoun_8

Summary of Significant Accounting Policies, Other Assets (Details) - USD ($) $ in Thousands	Dec. 31, 2021	Dec. 31, 2020
Other Assets [Abstract]
Deferred taxes	$ 26,483	$ 35,414
Deposits for noncancelable operating leases	17,121	20,783
Cash surrender value for life insurance policies	49,851	45,453
Right-of-use assets, Financing, net	6,477	9,385
Long-term Investments	35,868	11,344
Other	39,660	15,703
Total other assets	$ 175,460	$ 138,082
Right-of-use assets, Financing, net Statement of Financial Position [Extensible Enumeration]	Total other assets	Total other assets

Summary of Significant Accoun_9

Summary of Significant Accounting Policies, Accrued Expenses (Details) - USD ($) $ in Thousands	Dec. 31, 2021	Dec. 31, 2020
Accrued Expenses [Abstract]
Accrued sales force commissions and other payments	$ 139,793	$ 149,481
Accrued income taxes	0	13,921
Accrued other taxes	31,135	45,018
Accrued payroll and other employee expenses	53,641	65,272
Accrued payable to vendors	45,347	47,201
Short-term operating lease liability	33,427	44,981
Accrued royalties	1,095	1,008
Sales return reserve	3,513	3,978
Deferred revenue	33,139	35,054
Other	31,111	40,768
Total accrued expenses	$ 372,201	$ 446,682
Short-term operating lease liability, Statement of Financial Position [Extensible List]	Total accrued expenses	Total accrued expenses

Summary of Significant Accou_10

Summary of Significant Accounting Policies, Other Liabilities (Details) - USD ($) $ in Thousands	Dec. 31, 2021	Dec. 31, 2020
Other Liabilities [Abstract]
Deferred tax liabilities	$ 2,385	$ 626
Reserve for other tax liabilities	21,774	22,731
Liability for deferred compensation plan	54,213	47,543
Contingent consideration	10,341	3,125
Finance lease liabilities	5,318	7,728
Asset retirement obligation	5,408	6,717
Other	7,035	13,811
Total other liabilities	$ 106,474	$ 102,281
Finance lease liabilities, Statement of Financial Position [Extensible Enumeration]	Total other liabilities	Total other liabilities

Summary of Significant Accou_11

Summary of Significant Accounting Policies, Revenue Recognition (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Revenue Recognition [Abstract]
Sales returns	$ 52.1	$ 49.5	$ 52.2
Allowance for Product Returns [Member]
Revenue Recognition [Abstract]
Accrued reserve	$ 3.5	$ 4

Summary of Significant Accou_12

Summary of Significant Accounting Policies, Contract Liabilities - Customer Loyalty Programs (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Contract Liabilities - Customer Loyalty Programs [Abstract]
Contract liabilities for customer loyalty programs	$ 22	$ 18.2
Contract liabilities impact to revenue	$ (3.8)	$ (5.7)	$ 1.3

Summary of Significant Accou_13

Summary of Significant Accounting Policies, Advertising Expenses (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
General and Administrative Expenses [Member]
Advertising Expenses [Abstract]
Advertising costs incurred	$ 15.5	$ 14.7	$ 16.3

Summary of Significant Accou_14

Summary of Significant Accounting Policies, Research and Development (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Research and Development [Abstract]
Research and development expense	$ 27.2	$ 23.3	$ 30.1

Summary of Significant Accou_15

Summary of Significant Accounting Policies, Uncertain Tax Positions (Details) - Multiple Foreign and Domestic Authorities [Member] - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Reconciliation of Unrecognized Tax Benefits [Roll Forward]
Gross balance at beginning of year	$ 17,620	$ 13,507	$ 11,456
Increases related to prior year tax positions	4,146	2,958	775
Increases related to current year tax positions	1,794	3,302	2,273
Settlements	(5,494)	(1,091)	0
Decreases due to lapse of statutes of limitations	(2,409)	(1,377)	(1,051)
Currency adjustments	(567)
Currency adjustments		321	54
Gross balance at end of year	15,090	17,620	13,507
Uncertain Tax Positions [Abstract]
Unrecognized tax benefits that would impact effective tax rate	15,100	17,600
Interest and penalties expenses	1,600	1,500	700
Accrued interest and penalties	6,700	$ 5,100	$ 3,600
Minimum [Member]
Uncertain Tax Positions [Abstract]
Estimated increase in gross unrecognized tax benefits within next 12 months	$ 100
Maximum [Member]
Uncertain Tax Positions [Abstract]
Statute of limitations related to income tax examinations	10 years
Uncertain Tax Positions [Abstract]
Estimated increase in gross unrecognized tax benefits within next 12 months	$ 1,000

Summary of Significant Accou_16

Summary of Significant Accounting Policies, Foreign Currency Translation (Details) - USD ($) $ in Millions	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Foreign Currency Translation [Abstract]
Cumulative translation adjustment related to foreign currency adjustment	$ (79.1)	$ (65.6)	$ (85.3)
Cumulative translation adjustment related to foreign currency adjustment, tax	$ 7.5	$ 7.1	$ 7.4

Summary of Significant Accou_17

Summary of Significant Accounting Policies, Classification of a Highly Inflationary Economy (Details)	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Argentina [Member] | Net Sales [Member] | Geographic Concentration Risk [Member] | Maximum [Member]
Operations in Argentina [Abstract]
Concentration percentage	2.00%	2.00%	2.00%

Summary of Significant Accou_18

Summary of Significant Accounting Policies, Fair Value of Financial Instruments (Details) - USD ($) $ in Millions	Dec. 31, 2021	Dec. 31, 2020
Fair Value of Financial Instruments [Abstract]
Fair value of debt	$ 377.5	$ 337.5

Summary of Significant Accou_19

Summary of Significant Accounting Policies, Stock-Based Compensation (Details) - General and Administrative Expense [Member] - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Stock-Based Compensation [Abstract]
Compensation expense related to equity compensation plans	$ 23.2	$ 24.1	$ 9.9
Reversal of compensation expense for certain performance based awards no longer expected to vest	$ 0	$ 0	$ 4.3

Property and Equipment (Details

Property and Equipment (Details) - USD ($) $ in Thousands		12 Months Ended
		Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Property and Equipment [Abstract]
Property and equipment		$ 819,214	$ 818,496
Less: accumulated depreciation		(365,540)	(350,315)
Property and equipment, net		453,674	468,181
Depreciation expense		62,900	62,500	$ 61,700
Impairment charges		13,700
Land [Member]
Property and Equipment [Abstract]
Property and equipment		45,027	45,242
Buildings [Member]
Property and Equipment [Abstract]
Property and equipment		281,192	278,779
Construction in Progress [Member]
Property and Equipment [Abstract]
Property and equipment	[1]	44,021	34,954
Furniture and Fixtures [Member]
Property and Equipment [Abstract]
Property and equipment		147,786	146,413
Computers and Equipment [Member]
Property and Equipment [Abstract]
Property and equipment		162,746	137,914
Leasehold Improvements [Member]
Property and Equipment [Abstract]
Property and equipment		129,675	164,963
Scanners [Member]
Property and Equipment [Abstract]
Property and equipment		6,746	8,119
Vehicles [Member]
Property and Equipment [Abstract]
Property and equipment		2,021	2,112
Internal-Use Software Development Costs [Member]
Property and Equipment [Abstract]
Property and equipment		$ 11,000	$ 13,600
[1]	Construction in progress includes $11.0 million and $13.6 million as of December 31, 2021 and 2020, respectively, of eligible capitalized internal-use software development costs which will be reclassified to computers and equipment when placed into service.

Goodwill (Details)

Goodwill (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
Goodwill [Abstract]
Goodwill	$ 206,432	$ 202,979
Mainland China [Member]
Goodwill [Abstract]
Goodwill	32,179	32,179
Americas [Member]
Goodwill [Abstract]
Goodwill	9,449	9,449
South Korea [Member]
Goodwill [Abstract]
Goodwill	29,261	29,261
Southeast Asia/Pacific [Member]
Goodwill [Abstract]
Goodwill	18,537	18,537
EMEA [Member]
Goodwill [Abstract]
Goodwill	2,875	2,875
Japan [Member]
Goodwill [Abstract]
Goodwill	16,019	16,019
Hong Kong/Taiwan [Member]
Goodwill [Abstract]
Goodwill	6,634	6,634
Manufacturing [Member]
Goodwill [Abstract]
Goodwill	78,875	78,875
Grow Tech [Member]
Goodwill [Abstract]
Goodwill	0	9,150
Impairment charges	9,200
Rhyz Other [Member]
Goodwill [Abstract]
Goodwill	$ 12,603	$ 0

Other Intangible Assets, Indefi

Other Intangible Assets, Indefinite Life Intangible Assets (Details) - USD ($) $ in Thousands	Dec. 31, 2021	Dec. 31, 2020
Indefinite Life Intangible Assets [Abstract]
Indefinite life intangible assets	$ 24,599	$ 28,362
Trademarks and Trade Names [Member]
Indefinite Life Intangible Assets [Abstract]
Indefinite life intangible assets	24,599	24,599
Other Indefinite Lived Intangibles [Member]
Indefinite Life Intangible Assets [Abstract]
Indefinite life intangible assets	$ 0	$ 3,763

Other Intangible Assets, Finite

Other Intangible Assets, Finite Life Intangible Assets (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Finite Life Intangible Assets [Abstract]
Gross carrying amount	$ 156,320	$ 162,100
Accumulated amortization	$ 103,928	100,930
Weighted-average amortization period	14 years
Amortization expense	$ 11,700	9,800	$ 13,400
Scanner Technology [Member]
Finite Life Intangible Assets [Abstract]
Gross carrying amount	40,716	40,716
Accumulated amortization	$ 40,716	40,716
Weighted-average amortization period	18 years
Developed Technology [Member]
Finite Life Intangible Assets [Abstract]
Gross carrying amount	$ 43,841	32,546
Accumulated amortization	$ 24,697	21,680
Weighted-average amortization period	14 years
Sales Force Network [Member]
Finite Life Intangible Assets [Abstract]
Gross carrying amount	$ 11,598	11,598
Accumulated amortization	$ 11,598	11,598
Weighted-average amortization period	15 years
Trademarks [Member]
Finite Life Intangible Assets [Abstract]
Gross carrying amount	$ 8,989	6,145
Accumulated amortization	$ 3,827	2,938
Weighted-average amortization period	10 years
Other [Member]
Finite Life Intangible Assets [Abstract]
Gross carrying amount	$ 51,176	71,095
Accumulated amortization	$ 23,090	$ 23,998
Weighted-average amortization period	10 years

Other Intangible Assets, Annual

Other Intangible Assets, Annual Estimated Future Amortization Expense (Details) $ in Thousands	12 Months Ended
	Dec. 31, 2021USD ($)
Annual Estimated Future Amortization Expense [Abstract]
2022	$ 9,282
2023	9,135
2024	8,625
2025	7,502
2026	7,135
Grow Tech [Member]
Impairment Charges [Abstract]
Impairment charge related to indefinite lived intangible assets	3,800
Impairment charge related to finite lived intangible assets	$ 5,200

Long-Term Debt, Credit Agreemen

Long-Term Debt, Credit Agreement (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2021	Apr. 18, 2018
Credit Agreement [Member] | Maximum [Member]
Long-term Debt, Current and Noncurrent [Abstract]
Consolidated leverage ratio	2.25
Credit Agreement [Member] | Minimum [Member]
Long-term Debt, Current and Noncurrent [Abstract]
Consolidated interest coverage ratio	3
Term Loan Facility [Member]
Long-term Debt, Current and Noncurrent [Abstract]
Original principal amount	$ 400	$ 400
Term of loan	5 years
Term Loan Facility [Member] | First Year [Member]
Long-term Debt, Current and Noncurrent [Abstract]
Annual amortization percentage	5.00%
Term Loan Facility [Member] | Second Year [Member]
Long-term Debt, Current and Noncurrent [Abstract]
Annual amortization percentage	5.00%
Term Loan Facility [Member] | Third Year [Member]
Long-term Debt, Current and Noncurrent [Abstract]
Annual amortization percentage	7.50%
Term Loan Facility [Member] | Fourth Year [Member]
Long-term Debt, Current and Noncurrent [Abstract]
Annual amortization percentage	7.50%
Term Loan Facility [Member] | Fifth Year [Member]
Long-term Debt, Current and Noncurrent [Abstract]
Annual amortization percentage	10.00%
Revolving Credit Facility [Member]
Long-term Debt, Current and Noncurrent [Abstract]
Borrowing capacity		$ 350
Term of loan	5 years

Long-Term Debt, Debt Facilities

Long-Term Debt, Debt Facilities (Details) - USD ($) $ in Thousands		12 Months Ended
		Dec. 31, 2021	Dec. 31, 2020	Apr. 18, 2018
Long-term Debt [Abstract]
Balance	[1]	$ 307,500
Current portion of long-term debt		107,500	$ 30,000
Unamortized debt issuance costs		1,200
Credit Agreement [Member]
Long-term Debt [Abstract]
Unamortized debt issuance costs		1,200	2,100
Credit Agreement Term Loan Facility [Member]
Long-term Debt [Abstract]
Original principal amount		400,000		$ 400,000
Balance	[2],[3]	$ 307,500	337,500
Interest rate		Variable 30 day: 1.85%
Interest rate		1.85%
Term of variable rate		30 days
Repayment terms		35% of the principal amount is payable in increasing quarterly installments over a five-year period that began on June 30, 2018, with the remainder payable at the end of the five-year term.
Percentage of principal payable in installments		35.00%
Term of loan		5 years
Current portion of long-term debt		$ 37,500	30,000
Credit Agreement Revolving Credit Facility [Member]
Long-term Debt [Abstract]
Balance	[2],[3]	$ 70,000	$ 0
Interest rate		Variable 30 day: 1.85%
Interest rate		1.85%
Term of variable rate		30 days
Repayment terms		Revolving line of credit expires April 18, 2023.
Term of loan		5 years
[1]	The carrying value of the debt reflects the amounts stated in the above table less debt issuance costs of $1.2 million, which is not reflected in this table.
[2]	As of December 31, 2021 and 2020, the current portion of the Company’s debt (i.e. becoming due in the next 12 months) included $37.5 million and $30.0 million, respectively, of the balance of its term loan under the Credit Agreement.
[3]	The carrying value of the debt reflects the amounts stated in the above table, less debt issuance costs of $1.2 million and $2.1 million as of December 31, 2021 and 2020, respectively, related to the Credit Agreement, which are not reflected in this table.

Long-Term Debt, Maturities of L

Long-Term Debt, Maturities of Long-Term Debt (Details) $ in Thousands	Dec. 31, 2021USD ($)
Maturities of Long-term Debt [Abstract]
2022	$ 37,500
2023	270,000
2024	0
2025	0
2026	0
Thereafter	0
Total	307,500	[1]
Unamortized debt issuance costs	$ 1,200
[1]	The carrying value of the debt reflects the amounts stated in the above table less debt issuance costs of $1.2 million, which is not reflected in this table.

Leases (Details)

Leases (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Leases [Abstract]
Weighted average remaining lease term for operating leases	7 years 3 months 18 days
Weighted average remaining lease term for finance lease	3 years 8 months 12 days
Weighted average discount rate for operating leases	3.80%
Weighted average discount rate for finance lease	3.80%
Operating Lease Expense [Abstract]
Operating lease cost	$ 48,447	$ 51,828	$ 51,072
Variable lease cost	5,734	4,366	3,387
Short-term lease cost	592	1,056	169
Sublease income	(5,663)	(5,052)	(5,743)
Finance Lease Expense [Abstract]
Amortization of right-of-use assets	2,398	1,023	0
Interest on lease liabilities	319	154	0
Total lease expense	51,827	53,375	48,885
Supplemental Cash Flow Information Related to Leases [Abstract]
Operating cash outflow from operating leases	51,570	56,395	54,993
Operating cash outflow from finance leases	322	138	0
Financing cash outflow from finance leases	1,871	709	0
Right-of-use assets obtained in exchange for operating lease obligations	25,427	82,662	184,502
Right-of-use assets obtained in exchange for finance lease obligations	74	$ 9,206	$ 0
Maturities of Operating Lease Liabilities [Abstract]
2022	35,960
2023	24,806
2024	19,254
2025	14,336
2026	7,341
Thereafter	36,612
Total	138,309
Less: Finance charges	17,658
Total principal liability	120,651
Maturities of Finance Lease Liabilities [Abstract]
2021	2,152
2022	2,064
2023	1,954
2024	1,381
2025	260
Thereafter	0
Total	7,811
Less: Finance charges	548
Total principal liability	7,263
Additional lease liabilities not yet commenced	$ 5,200
Minimum [Member]
Leases [Abstract]
Remaining lease terms	1 year
Maximum [Member]
Leases [Abstract]
Remaining lease terms	23 years
Extension period for leases	20 years
Termination period for leases	1 year

Capital Stock, Authorized Capit

Capital Stock, Authorized Capital Stock (Details)	12 Months Ended
	Dec. 31, 2021Vote$ / sharesshares	Dec. 31, 2020$ / sharesshares
Capital Stock [Abstract]
Preferred stock, authorized (in shares)	25,000,000
Preferred stock, par value (in dollars per share) | $ / shares	$ 0.001
Common stock, shares authorized (in shares)	500,000,000	500,000,000
Common stock, par value (in dollars per share) | $ / shares	$ 0.001	$ 0.001
Preferred stock, shares outstanding (in shares)	0	0
Common Class A [Member]
Capital Stock [Abstract]
Common stock, shares authorized (in shares)	500,000,000
Common stock, par value (in dollars per share) | $ / shares	$ 0.001
Number of votes per share | Vote	1
Common Class B [Member]
Capital Stock [Abstract]
Common stock, shares authorized (in shares)	100,000,000
Common stock, par value (in dollars per share) | $ / shares	$ 0.001
Common stock, shares outstanding (in shares)	0	0

Capital Stock, Weighted Average

Capital Stock, Weighted Average Shares Outstanding (Details) - shares shares in Thousands	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Weighted Average Shares Outstanding [Abstract]
Basic weighted-average common shares outstanding (in shares)	50,193	52,296	55,518
Effect of Dilutive Securities [Abstract]
Stock awards and options (in shares)	1,234	469	409
Diluted weighted-average common shares outstanding (in shares)	51,427	52,765	55,927
Stock Options [Member]
Weighted Average Shares Outstanding [Abstract]
Anti-dilutive shares excluded from calculation of diluted earnings per share (in shares)	100	400	1,400

Capital Stock, Dividends (Detai

Capital Stock, Dividends (Details) - USD ($) $ / shares in Units, $ in Thousands

1 Months Ended

3 Months Ended

12 Months Ended

Feb. 16, 2022

Dec. 31, 2021

Sep. 30, 2021

Jun. 30, 2021

Mar. 31, 2021

Dec. 31, 2020

Sep. 30, 2020

Jun. 30, 2020

Mar. 31, 2020

Dec. 31, 2021

Dec. 31, 2020

Dec. 31, 2019

Dividends [Abstract]

Payment of cash dividends

$ 76,272

$ 78,387

$ 82,189

Dividend Declared 2021-Q1 [Member]

Dividends [Abstract]

Cash dividend paid (in dollars per share)

$ 0.38

Dividend Declared 2021-Q2 [Member]

Dividends [Abstract]

Cash dividend paid (in dollars per share)

$ 0.38

Dividend Declared 2021-Q3 [Member]

Dividends [Abstract]

Cash dividend paid (in dollars per share)

$ 0.38

Dividend Declared 2021-Q4 [Member]

Dividends [Abstract]

Cash dividend paid (in dollars per share)

$ 0.38

Dividend Declared 2020-Q1 [Member]

Dividends [Abstract]

Cash dividend paid (in dollars per share)

$ 0.375

Dividend Declared 2020-Q2 [Member]

Dividends [Abstract]

Cash dividend paid (in dollars per share)

$ 0.375

Dividend Declared 2020-Q3 [Member]

Dividends [Abstract]

Cash dividend paid (in dollars per share)

$ 0.375

Dividend Declared 2020-Q4 [Member]

Dividends [Abstract]

Cash dividend paid (in dollars per share)

$ 0.375

Dividend Declared 2022-Q1 [Member] | Subsequent Event [Member]

Dividends [Abstract]

Dividend payable per share (in dollars per share)

$ 0.385

Dividend payable, date to be paid

Mar. 9, 2022

Dividend payable, date of record

Feb. 28, 2022

Capital Stock, Repurchases of C

Capital Stock, Repurchases of Common Stock (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019	Jul. 31, 2018
Repurchases of Common Stock [Abstract]
Class A common stock repurchased	$ 80,420	$ 144,334	$ 825
2018 Stock Repurchase Plan [Member]
Repurchases of Common Stock [Abstract]
Authorized amount				$ 500,000
Amount available for repurchases	245,400
Treasury Stock [Member]
Repurchases of Common Stock [Abstract]
Class A common stock repurchased	$ 80,420	$ 144,334	$ 825
Treasury Stock [Member] | 2018 Stock Repurchase Plan [Member]
Repurchases of Common Stock [Abstract]
Class A common stock repurchased (in shares)	1,600,000	5,100,000	14,000
Class A common stock repurchased	$ 80,400	$ 144,300	$ 800

Stock-Based Compensation, Equit

Stock-Based Compensation, Equity Incentive Plans (Details) - 2010 Omnibus Incentive Plan [Member] - shares shares in Millions	Jun. 03, 2020	May 24, 2016	Jun. 03, 2013	Dec. 31, 2021	Apr. 30, 2010
Stock-Based Compensation [Abstract]
Number of shares authorized for issuance (in shares)					7
Number of additional shares authorized for issuance (in shares)	5.9	3.8	3.2
Stock Options [Member]
Stock-Based Compensation [Abstract]
Contractual term				7 years

Stock-Based Compensation, Stock

Stock-Based Compensation, Stock Option Valuation Assumptions (Details) - Stock Options [Member] - $ / shares		12 Months Ended
		Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Fair Value Assumptions [Abstract]
Weighted-average grant date fair value of grants (in dollars per share)		$ 16.10	$ 8.59	$ 19.72
Risk-free interest rate	[1]	0.50%	1.40%	2.50%
Dividend yield	[2]	2.90%	2.90%	2.70%
Expected volatility	[3]	49.50%	40.70%	42.40%
Expected life in months	[4]	56 months	59 months	60 months
Minimum [Member]
Fair Value Assumptions [Abstract]
Contractual life		7 years
Maximum [Member]
Fair Value Assumptions [Abstract]
Contractual life		10 years
[1]	The risk-free interest rate is based upon the rate on a zero-coupon U.S. Treasury bill, for periods within the contractual life of the option, in effect at the time of the grant.
[2]	The dividend yield is based on the average of historical stock prices and actual dividends paid.
[3]	Expected volatility is based on the historical volatility of the Company’s stock price, over a period similar to the expected life of the option.
[4]	The expected term of the option is based on the historical employee exercise behavior, the vesting terms of the respective option, and a contractual life of either seven or .

Stock-Based Compensation, Sto_2

Stock-Based Compensation, Stock Options (Details) - USD ($) $ / shares in Units, $ in Thousands	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Number of Shares [Roll Forward]
Exercised (in shares)	(700,000)	(400,000)	0
Stock Options [Member]
Number of Shares [Roll Forward]
Outstanding at beginning of year (in shares)	3,168,600
Granted (in shares)	877,900
Exercised (in shares)	(486,400)
Forfeited/cancelled/expired (in shares)	(801,800)
Outstanding at end of year (in shares)	2,758,300	3,168,600
Exercisable at end of year (in shares)	1,512,800
Weighted-Average Exercise Price [Roll Forward]
Outstanding at beginning of year (in dollars per share)	$ 44.76
Granted (in dollars per share)	41.68
Exercised (in dollars per share)	34.23
Forfeited/cancelled/expired (in dollars per share)	64.53
Outstanding at end of year (in dollars per share)	39.90	$ 44.76
Exercisable at end of year (in dollars per share)	$ 38.79
Remaining Contractual Term and Aggregate Intrinsic Value [Abstract]
Outstanding options, weighted-average remaining contractual term	3 years 11 months 12 days
Outstanding options, aggregate intrinsic value	$ 35,657
Exercisable options, weighted-average remaining contractual term	2 years 8 months 19 days
Exercisable options, aggregate intrinsic value	$ 21,665
Service-Based Options [Member]
Number of Shares [Roll Forward]
Outstanding at beginning of year (in shares)	770,600
Granted (in shares)	0
Exercised (in shares)	(188,800)
Forfeited/cancelled/expired (in shares)	(43,600)
Outstanding at end of year (in shares)	538,200	770,600
Exercisable at end of year (in shares)	538,200
Weighted-Average Exercise Price [Roll Forward]
Outstanding at beginning of year (in dollars per share)	$ 38.71
Granted (in dollars per share)	0
Exercised (in dollars per share)	37.74
Forfeited/cancelled/expired (in dollars per share)	77.71
Outstanding at end of year (in dollars per share)	35.89	$ 38.71
Exercisable at end of year (in dollars per share)	$ 35.89
Remaining Contractual Term and Aggregate Intrinsic Value [Abstract]
Outstanding options, weighted-average remaining contractual term	1 year 1 month 24 days
Outstanding options, aggregate intrinsic value	$ 8,303
Exercisable options, weighted-average remaining contractual term	1 year 1 month 24 days
Exercisable options, aggregate intrinsic value	$ 8,303
Performance-Based Options [Member]
Number of Shares [Roll Forward]
Outstanding at beginning of year (in shares)	2,398,000
Granted (in shares)	877,900
Exercised (in shares)	(297,600)
Forfeited/cancelled/expired (in shares)	(758,200)
Outstanding at end of year (in shares)	2,220,100	2,398,000
Exercisable at end of year (in shares)	974,600
Weighted-Average Exercise Price [Roll Forward]
Outstanding at beginning of year (in dollars per share)	$ 46.71
Granted (in dollars per share)	41.68
Exercised (in dollars per share)	32
Forfeited/cancelled/expired (in dollars per share)	63.77
Outstanding at end of year (in dollars per share)	40.87	$ 46.71
Exercisable at end of year (in dollars per share)	$ 40.39
Remaining Contractual Term and Aggregate Intrinsic Value [Abstract]
Outstanding options, weighted-average remaining contractual term	4 years 7 months 13 days
Outstanding options, aggregate intrinsic value	$ 27,353
Exercisable options, weighted-average remaining contractual term	3 years 7 months 2 days
Exercisable options, aggregate intrinsic value	$ 13,361

Stock-Based Compensation, Sto_3

Stock-Based Compensation, Stock Options Exercised (Details) - Stock Options [Member] - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Stock-Based Compensation [Abstract]
Cash proceeds from stock options exercised	$ 14,435	$ 7,419	$ 368
Tax expense realized for stock options exercised		(459)
Tax benefit realized for stock options exercised	807		430
Intrinsic value of stock options exercised	$ 8,402	$ 5,232	$ 934

Stock-Based Compensation, Nonve

Stock-Based Compensation, Nonvested Restricted Stock Awards (Details) - Restricted Stock Awards [Member]	12 Months Ended
	Dec. 31, 2021$ / sharesshares
Number of Shares [Roll Forward]
Nonvested at beginning of year (in shares) | shares	931,100
Granted (in shares) | shares	380,400
Vested (in shares) | shares	(307,600)
Forfeited (in shares) | shares	(119,000)
Nonvested at end of year (in shares) | shares	884,900
Weighted-Average Grant Date Fair Value [Abstract]
Nonvested, beginning balance (in dollars per share) | $ / shares	$ 46.38
Granted (in dollars per share) | $ / shares	50.39
Vested (in dollars per share) | $ / shares	48.59
Forfeited (in dollars per share) | $ / shares	45.95
Nonvested, Ending Balance (in dollars per share) | $ / shares	$ 47.39

Stock-Based Compensation, Sto_4

Stock-Based Compensation, Stock-Based Compensation Expense (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Stock-Based Compensation Expense [Abstract]
Stock-based compensation expense (income)	$ 23,194	$ 24,060	$ 9,909
Stock Options [Member]
Unrecognized Stock-Based Compensation Expense [Abstract]
Unrecognized stock-based compensation expense	$ 5,500
Unrecognized stock-based compensation expense, period for recognition	1 year 3 months 18 days
Restricted Stock Awards [Member]
Unrecognized Stock-Based Compensation Expense [Abstract]
Unrecognized stock-based compensation expense	$ 25,300
Unrecognized stock-based compensation expense, period for recognition	2 years 4 months 24 days
Service-Based Options [Member]
Stock-Based Compensation Expense [Abstract]
Stock-based compensation expense (income)	$ 0	300	2,600
Service-Based Restricted Stock Units [Member]
Stock-Based Compensation Expense [Abstract]
Stock-based compensation expense (income)	15,400	13,900	11,500
Performance-Based Options [Member]
Stock-Based Compensation Expense [Abstract]
Stock-based compensation expense (income)	7,800	9,900	(4,100)
Performance Stock Units [Member]
Stock-Based Compensation Expense [Abstract]
Stock-based compensation expense (income)	$ 0	$ 0	$ 100

Fair Value and Equity Investm_3

Fair Value and Equity Investments, Fair Value (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
Contingent Consideration [Member]
Changes in Fair Value of Level 3 Contingent Consideration [Roll Forward]
Beginning balance	$ (3,125)	$ 0
Additions from acquisitions	(8,702)	(3,125)
Changes in fair value of contingent consideration	1,486	0
Ending balance	(10,341)	(3,125)
Fair Value on a Recurring Basis [Member]
Financial Assets (Liabilities) [Abstract]
Cash equivalents and current investments	66,477	56,628
Derivative financial instruments asset	6,590	1,145
Life insurance contracts	49,851	45,453
Derivative financial instruments liability		(105)
Contingent consideration	(10,341)	(3,125)
Financial assets (liabilities)	112,577	99,996
Restricted current investments	5,200	21,200
Fair Value on a Recurring Basis [Member] | Level 1 [Member]
Financial Assets (Liabilities) [Abstract]
Cash equivalents and current investments	66,477	56,628
Derivative financial instruments asset	0	0
Life insurance contracts	0	0
Derivative financial instruments liability		0
Contingent consideration	0	0
Financial assets (liabilities)	66,477	56,628
Fair Value on a Recurring Basis [Member] | Level 2 [Member]
Financial Assets (Liabilities) [Abstract]
Cash equivalents and current investments	0	0
Derivative financial instruments asset	6,590	1,145
Life insurance contracts	0	0
Derivative financial instruments liability		(105)
Contingent consideration	0	0
Financial assets (liabilities)	6,590	1,040
Fair Value on a Recurring Basis [Member] | Level 3 [Member]
Financial Assets (Liabilities) [Abstract]
Cash equivalents and current investments	0	0
Derivative financial instruments asset	0	0
Life insurance contracts	49,851	45,453
Derivative financial instruments liability		0
Contingent consideration	(10,341)	(3,125)
Financial assets (liabilities)	39,510	42,328
Life Insurance Contracts [Member]
Changes in Fair Value of Level 3 Marketable Securities [Roll Forward]
Beginning balance	45,453	41,707
Actual return on plan assets	5,153	3,746
Purchases and issuances	6,261	0
Sales and settlements	(7,016)	0
Transfers into Level 3	0	0
Ending balance	$ 49,851	$ 45,453

Fair Value and Equity Investm_4

Fair Value and Equity Investments, Equity Investments (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Equity Investments [Abstract]
Upward fair value adjustments on equity securities	$ 18,077	$ 0	$ 0
Equity Securities [Member]
Equity Investments [Abstract]
Carrying amount of equity securities without readily determinable fair values	28,100	$ 5,000
Additional investment made	5,000
Equity Securities [Member] | Other Income (Expense), Net [Member]
Equity Investments [Abstract]
Upward fair value adjustments on equity securities	$ 18,100

Income Taxes, Consolidated Inco

Income Taxes, Consolidated Income Before Provision for Income Taxes (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Consolidated Income Before Provision for Income Taxes [Abstract]
U.S.	$ 45,371	$ 71,138	$ 24,211
Foreign	187,088	185,094	230,961
Income before provision for income taxes	$ 232,459	$ 256,232	$ 255,172

Income Taxes, Current and Defer

Income Taxes, Current and Deferred Taxes (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Current [Abstract]
Federal	$ 0	$ 0	$ 0
State	1,458	1,629	2,213
Foreign	77,393	77,079	79,694
Current income tax expense (benefit)	78,851	78,708	81,907
Deferred [Abstract]
Federal	3,705	(14,430)	(8,878)
State	(38)	(563)	(473)
Foreign	2,675	1,162	9,063
Deferred income tax expense (benefit)	6,342	(13,831)	(288)
Provision for income taxes	$ 85,193	$ 64,877	$ 81,619

Income Taxes, Deferred Tax Asse

Income Taxes, Deferred Tax Assets and Liabilities (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
Deferred Tax Assets [Abstract]
Inventory differences	$ 5,859	$ 6,181
Foreign tax credit and other foreign benefits	69,401	57,720
Stock-based compensation	9,392	8,925
Accrued expenses not deductible until paid	36,401	42,694
Foreign currency exchange	605	1,403
Net operating losses	9,479	8,667
Capitalized research and development	22,962	23,019
R&D credit carryforward	1,451	1,229
Other	34	45
Gross deferred tax assets	155,584	149,883
Deferred Tax Liabilities [Abstract]
Foreign withholding taxes	15,412	20,207
Intangibles step-up	4,446	4,623
Overhead allocation to inventory	3,373	2,684
Amortization of intangibles	21,936	18,551
Other	6,133	1,690
Gross deferred tax liabilities	51,300	47,755
Valuation allowance	(80,186)	(67,340)
Deferred taxes, net	24,098	$ 34,788
Tax Credit Carryforwards [Abstract]
Valuation allowance on foreign tax credit carryforward, interest expense limitation, and R&D credit carryforward	$ 70,900
Minimum [Member]
Tax Credit Carryforwards [Abstract]
Expiration date	Dec. 31, 2026
Maximum [Member]
Tax Credit Carryforwards [Abstract]
Expiration date	Dec. 31, 2030
Foreign [Member]
Operating Loss Carryforwards [Abstract]
Operating loss carryforwards	$ 26,700
Operating loss carryforwards subject to expiration	12,400
Operating loss carryforwards not subject to expiration	14,300
Valuation allowance on operating loss carryforwards	25,800
Tax effected valuation allowance on operating loss carryforwards	$ 9,300
Foreign [Member] | Minimum [Member]
Operating Loss Carryforwards [Abstract]
Expiration date	Dec. 31, 2022
Foreign [Member] | Maximum [Member]
Operating Loss Carryforwards [Abstract]
Expiration date	Dec. 31, 2031

Income Taxes, Deferred Tax As_2

Income Taxes, Deferred Tax Asset Valuation Adjustments (Details) - USD ($) $ in Thousands		12 Months Ended
		Dec. 31, 2021		Dec. 31, 2020		Dec. 31, 2019
Valuation Allowance [Roll Forward]
Recognition of valuation allowance on foreign tax credit carryforwards		$ 11,900				$ 9,800
Deferred Tax Asset Valuation Allowance [Member]
Valuation Allowance [Roll Forward]
Beginning balance		67,340		$ 77,042		68,697
Additions charged to cost and expenses		12,674	[1]	2,154	[2]	10,913	[3]
Decreases		0	[4]	(12,100)	[5]	(3,343)	[6]
Adjustments	[7]	172		244		775
Ending balance		$ 80,186		$ 67,340		$ 77,042
[1]	Increase $11.9 million that was recorded on the foreign tax credit carryforward due to the disposal of the Companies Grow Tech segment. The additional amount is due to
[2]	Increase net operating losses in foreign markets .
[3]	Increase in valuation is due primarily to $9.8 million that was recorded on the foreign tax credit carryforward. The additional amount is due to net operating losses in foreign markets.
[4]	No decreases in 2021.
[5]	The .
[6]	The .
[7]	Represents the net currency effects of translating valuation allowances at current rates of exchange.

Income Taxes, Components of Def

Income Taxes, Components of Deferred Taxes, Net (Details) - USD ($) $ in Thousands	Dec. 31, 2021	Dec. 31, 2020
Income Taxes [Abstract]
Net noncurrent deferred tax assets	$ 26,483	$ 35,414
Net noncurrent deferred tax liabilities	2,385	626
Deferred taxes, net	$ 24,098	$ 34,788

Income Taxes, Reconciliation of

Income Taxes, Reconciliation of Statutory to Effective Tax Rate (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Effective income tax rate, continuing operations, tax rate reconciliation [Abstract]
Income taxes at statutory rate	21.00%	21.00%	21.00%
Excess tax benefit from equity award	(0.19%)	0.70%	0.02%
Non-U.S. income taxed at different rates	6.06%	3.37%	3.09%
Foreign withholding taxes	4.71%	5.21%	4.10%
Change in reserve for uncertain tax positions	(0.06%)	1.98%	1.07%
Valuation allowance recognized foreign tax credit & others	5.12%	(4.59%)	2.56%
Foreign-Derived Intangible Income (FDII)	(0.87%)	(2.78%)	(0.70%)
Other	0.88%	0.43%	0.85%
Effective income tax rate, continuing operations	36.65%	25.32%	31.99%
Cumulative amount of undistributed earnings of non-U.S. subsidiaries	$ 60
Incremental taxes if undistributed earnings on non-U.S. subsidiaries were repatriated	$ 6

Employee Benefit Plan (Details)

Employee Benefit Plan (Details) - 401(k) Defined Contribution Plan [Member] - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
401(k) Defined Contribution Plan [Abstract]
Maximum percentage of compensation that can be deferred	100.00%
Minimum age to make contributions	18 years
Percent of employees' base pay matched by employer	4.00%	4.00%	4.00%
Vesting period for Company's matching contributions	2 years
Compensation expense	$ 4.8	$ 4.4	$ 3.7
Additional discretionary contribution by employer, maximum percentage of employees' base pay	10.00%
Additional discretionary contribution by employer, annual vesting percentage	20.00%
Vesting period for Company's additional discretionary contributions	5 years

Deferred Compensation Plan (Det

Deferred Compensation Plan (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Deferred Compensation Plan [Abstract]
Percentage of participant's base salary contributed	5.00%	10.00%
Percentage of Company contributions that vest after ten years of service	50.00%
Number of years of service to qualify for 50% vesting in Company contributions	10 years
Percentage of Company contributions that vest annually thereafter	5.00%
Minimum age for participant's unvested company contributions to fully vest	60 years
Percentage of Company contributions that vest after five years of service	20.00%
Vesting period	5 years
Participant's vesting percentage	100.00%
Compensation expense	$ 4,000	$ 2,300	$ 1,800
Long-term deferred compensation liability	54,213	47,543
Investment in Rabbi Trust	$ 49,900	$ 45,500
Maximum [Member]
Deferred Compensation Plan [Abstract]
Percentage of participant's salary that can be deferred	80.00%
Percentage of participant's bonus or director fees that can be deferred	100.00%
Minimum [Member]
Deferred Compensation Plan [Abstract]
Number of years of service required for accelerated vesting above specified compensation level	10 years

Derivative Financial Instrume_3

Derivative Financial Instruments, Fair Value of Derivative Instruments on the Balance Sheet (Details) $ in Thousands	12 Months Ended
	Dec. 31, 2021USD ($)Derivatives	Dec. 31, 2020USD ($)
Derivatives and Hedging Activities [Abstract]
Loss to be reclassified to interest expense during next twelve months	$ (557)
Number of outstanding derivatives held | Derivatives	4
Notional amount	$ 200,000
Interest Rate Swaps [Member] | Designated as Hedging Instrument [Member] | Prepaid Expenses and Other [Member]
Derivatives and Hedging Activities [Abstract]
Fair value, asset	557	$ 0
Interest Rate Swaps [Member] | Designated as Hedging Instrument [Member] | Other Assets [Member]
Derivatives and Hedging Activities [Abstract]
Fair value, asset	6,033	1,145
Interest Rate Swaps [Member] | Designated as Hedging Instrument [Member] | Accrued Expenses [Member]
Derivatives and Hedging Activities [Abstract]
Fair value, liability	$ 0	$ 104

Derivative Financial Instrume_4

Derivative Financial Instruments, Effect of Cash Flow Hedge Accounting on Accumulated Other Comprehensive Income (Details) - Interest Rate Swaps [Member] - Designated as Hedging Instrument [Member] - Cash Flow Hedges [Member] - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Other Income/(Expense) [Member]
Derivatives and Hedging Activities [Abstract]
Gain (loss) reclassified from accumulated other comprehensive loss into income	$ (157)	$ (24)	$ 0
Other Comprehensive Loss [Member]
Derivatives and Hedging Activities [Abstract]
Gain (loss) recognized in OCI	$ 5,391	$ 1,017	$ 0

Segment Information, Revenue by

Segment Information, Revenue by Segment (Details) $ in Thousands		12 Months Ended
		Dec. 31, 2021USD ($)Segment	Dec. 31, 2020USD ($)	Dec. 31, 2019USD ($)
Segment Information [Abstract]
Number of reportable segments | Segment		10
Number of geographic segments | Segment		7
Number of Rhyz Investments segments | Segment		3
Revenue by Segment [Abstract]
Revenue		$ 2,695,669	$ 2,581,934	$ 2,420,416
Other [Member]
Revenue by Segment [Abstract]
Revenue		1,549	(17)	1,621
Operating Segment [Member] | Nu Skin [Member]
Revenue by Segment [Abstract]
Revenue		2,521,008	2,431,692	2,298,362
Operating Segment [Member] | Mainland China [Member]
Revenue by Segment [Abstract]
Revenue		568,774	625,538	722,526
Operating Segment [Member] | Americas [Member]
Revenue by Segment [Abstract]
Revenue		547,755	453,022	304,422
Operating Segment [Member] | South Korea [Member]
Revenue by Segment [Abstract]
Revenue		354,252	326,478	329,978
Operating Segment [Member] | Southeast Asia/Pacific [Member]
Revenue by Segment [Abstract]
Revenue		336,651	361,627	346,276
Operating Segment [Member] | EMEA [Member]
Revenue by Segment [Abstract]
Revenue		283,200	230,246	167,165
Operating Segment [Member] | Japan [Member]
Revenue by Segment [Abstract]
Revenue		266,216	273,681	260,039
Operating Segment [Member] | Hong Kong/Taiwan [Member]
Revenue by Segment [Abstract]
Revenue		162,611	161,117	166,335
Operating Segment [Member] | Rhyz Investments [Member]
Revenue by Segment [Abstract]
Revenue		174,661	150,242	122,054
Operating Segment [Member] | Manufacturing [Member]
Revenue by Segment [Abstract]
Revenue	[1]	172,120	149,339	121,917
Operating Segment [Member] | Grow Tech [Member]
Revenue by Segment [Abstract]
Revenue		2,104	903	137
Operating Segment [Member] | Rhyz Other [Member]
Revenue by Segment [Abstract]
Revenue		437	0	0
Intersegment [Member] | Manufacturing [Member]
Revenue by Segment [Abstract]
Revenue		$ 84,500	$ 39,400	$ 25,700
[1]	The Manufacturing segment had $84.5 million, $39.4 million and $25.7 million of intersegment revenue for the years ended December 31, 2021, 2020 and 2019, respectively.  Intersegment revenue is eliminated in the consolidated financial statements and in the table above.

Segment Information, Segment Co

Segment Information, Segment Contribution (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Segment Contribution [Abstract]
Operating income	$ 233,992	$ 257,564	$ 267,426
Other income (expense)	(1,533)	(1,332)	(12,254)
Income before provision for income taxes	232,459	256,232	255,172
Operating Segment [Member]
Segment Contribution [Abstract]
Operating income	543,178	571,777	535,292
Operating Segment [Member] | Nu Skin [Member]
Segment Contribution [Abstract]
Operating income	610,552	573,039	539,108
Operating Segment [Member] | Mainland China [Member]
Segment Contribution [Abstract]
Operating income	151,645	181,024	191,570
Operating Segment [Member] | Americas [Member]
Segment Contribution [Abstract]
Operating income	116,265	86,386	52,135
Operating Segment [Member] | South Korea [Member]
Segment Contribution [Abstract]
Operating income	114,034	100,933	99,892
Operating Segment [Member] | Southeast Asia/Pacific [Member]
Segment Contribution [Abstract]
Operating income	81,779	87,753	90,666
Operating Segment [Member] | EMEA [Member]
Segment Contribution [Abstract]
Operating income	41,988	24,078	10,195
Operating Segment [Member] | Japan [Member]
Segment Contribution [Abstract]
Operating income	67,511	68,027	61,081
Operating Segment [Member] | Hong Kong/Taiwan [Member]
Segment Contribution [Abstract]
Operating income	37,330	33,466	33,569
Operating Segment [Member] | Rhyz Investments [Member]
Segment Contribution [Abstract]
Operating income	(67,374)	(1,262)	(3,816)
Operating Segment [Member] | Manufacturing [Member]
Segment Contribution [Abstract]
Operating income	18,346	21,168	15,693
Operating Segment [Member] | Grow Tech [Member]
Segment Contribution [Abstract]
Operating income	(83,907)	(22,430)	(19,509)
Operating Segment [Member] | Rhyz Other [Member]
Segment Contribution [Abstract]
Operating income	(1,813)	0	0
Corporate and Other [Member]
Segment Contribution [Abstract]
Operating income	$ (309,186)	$ (314,213)	$ (267,866)

Segment Information, Depreciati

Segment Information, Depreciation and Amortization and Capital Expenditures (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Summarized Financial Information [Abstract]
Depreciation and amortization	$ 76,320	$ 73,991	$ 76,650
Capital expenditures	68,615	63,823	66,067
Operating Segments [Member] | Nu Skin [Member]
Summarized Financial Information [Abstract]
Depreciation and amortization	24,594	23,135	25,804
Capital expenditures	29,452	29,752	23,231
Operating Segments [Member] | Mainland China [Member]
Summarized Financial Information [Abstract]
Depreciation and amortization	13,345	11,056	10,496
Capital expenditures	24,382	19,363	14,814
Operating Segments [Member] | Americas [Member]
Summarized Financial Information [Abstract]
Depreciation and amortization	871	984	767
Capital expenditures	714	1,061	1,283
Operating Segments [Member] | South Korea [Member]
Summarized Financial Information [Abstract]
Depreciation and amortization	3,279	3,620	5,093
Capital expenditures	854	1,420	1,223
Operating Segments [Member] | Southeast Asia/Pacific [Member]
Summarized Financial Information [Abstract]
Depreciation and amortization	1,450	1,670	2,012
Capital expenditures	1,330	2,197	816
Operating Segments [Member] | EMEA [Member]
Summarized Financial Information [Abstract]
Depreciation and amortization	1,106	1,017	1,260
Capital expenditures	1,242	1,875	364
Operating Segments [Member] | Japan [Member]
Summarized Financial Information [Abstract]
Depreciation and amortization	906	1,876	3,866
Capital expenditures	194	3,128	1,528
Operating Segments [Member] | Hong Kong/Taiwan [Member]
Summarized Financial Information [Abstract]
Depreciation and amortization	3,637	2,912	2,310
Capital expenditures	736	708	3,203
Operating Segments [Member] | Rhyz Investments [Member]
Summarized Financial Information [Abstract]
Depreciation and amortization	18,232	13,173	10,697
Capital expenditures	15,705	16,865	13,533
Operating Segments [Member] | Manufacturing [Member]
Summarized Financial Information [Abstract]
Depreciation and amortization	11,765	8,081	6,689
Capital expenditures	14,022	14,366	6,595
Operating Segments [Member] | Grow Tech [Member]
Summarized Financial Information [Abstract]
Depreciation and amortization	4,888	5,092	4,008
Capital expenditures	1,683	2,499	6,938
Operating Segments [Member] | Other Rhyz Investments [Member]
Summarized Financial Information [Abstract]
Depreciation and amortization	1,579	0	0
Capital expenditures	0	0	0
Corporate and Other [Member]
Summarized Financial Information [Abstract]
Depreciation and amortization	33,494	37,683	40,149
Capital expenditures	$ 23,458	$ 17,206	$ 29,303

Segment Information, Revenue _2

Segment Information, Revenue by Major Market (Details) $ in Thousands	12 Months Ended
	Dec. 31, 2021USD ($)Market	Dec. 31, 2020USD ($)	Dec. 31, 2019USD ($)
Segment Information [Abstract]
Number of major markets | Market	4
Number of markets | Market	45
Segment Contribution [Abstract]
Revenue	$ 2,695,669	$ 2,581,934	$ 2,420,416
Major Market [Member] | Mainland China [Member]
Segment Contribution [Abstract]
Revenue	568,774	625,538	722,526
Major Market [Member] | South Korea [Member]
Segment Contribution [Abstract]
Revenue	354,252	326,478	329,978
Major Market [Member] | Japan [Member]
Segment Contribution [Abstract]
Revenue	266,216	273,681	260,039
Major Market [Member] | United States [Member]
Segment Contribution [Abstract]
Revenue	540,253	425,155	324,727
Major Market [Member] | All Others [Member]
Segment Contribution [Abstract]
Revenue	$ 966,174	$ 931,082	$ 783,146

Segment Information, Revenue _3

Segment Information, Revenue by Product Line (Details) - USD ($) $ in Thousands		12 Months Ended
		Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Revenue by Product Line [Abstract]
Revenue		$ 2,695,669	$ 2,581,934	$ 2,420,416
Beauty [Member]
Revenue by Product Line [Abstract]
Revenue	[1]	1,442,659	1,491,803	1,423,485
Devices and Related Consumables [Member]
Revenue by Product Line [Abstract]
Revenue		658,000	712,000	618,000
Wellness [Member]
Revenue by Product Line [Abstract]
Revenue	[1]	1,062,549	922,553	863,125
Other [Member]
Revenue by Product Line [Abstract]
Revenue	[2]	$ 190,461	$ 167,578	$ 133,806
[1]	Includes sales of beauty and wellness products in the core Nu Skin business. The beauty category includes $658 million, $712 million, $618 million in sales of devices and related consumables for the years ended December 31, 2021, 2020 and 2019, respectively.
[2]	Other includes the external revenue from the Rhyz companies along with a limited number of other products and services, including household products and technology services.

Segment Information, Long-Lived

Segment Information, Long-Lived Assets by Major Market (Details) - USD ($) $ in Thousands	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Long-Lived Assets by Major Market [Abstract]
Long-lived assets	$ 581,124	$ 632,670	$ 597,930
Major Market [Member] | United States [Member]
Long-Lived Assets by Major Market [Abstract]
Long-lived assets	335,020	348,028	354,410
Major Market [Member] | Mainland China [Member]
Long-Lived Assets by Major Market [Abstract]
Long-lived assets	149,124	152,312	136,845
Major Market [Member] | South Korea [Member]
Long-Lived Assets by Major Market [Abstract]
Long-lived assets	25,364	39,104	35,286
Major Market [Member] | Japan [Member]
Long-Lived Assets by Major Market [Abstract]
Long-lived assets	23,929	31,085	12,015
Major Market [Member] | All Others [Member]
Long-Lived Assets by Major Market [Abstract]
Long-lived assets	$ 47,687	$ 62,141	$ 59,374

Other Income (Expense), Net (De

Other Income (Expense), Net (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Other Income (Expense), Net [Abstract]
Other income (expense), net	$ (1,533)	$ (1,332)	$ (12,254)
Interest expense	$ 11,000	$ 13,100	$ 19,200

Supplemental Cash Flow Inform_2

Supplemental Cash Flow Information (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Supplemental Cash Flow Information [Abstract]
Cash paid for interest	$ 8.6	$ 11.2	$ 17.9
Cash paid for income taxes	$ 96	$ 56.2	$ 97.9

Acquisitions (Details)

Acquisitions (Details) - USD ($) $ in Thousands	1 Months Ended		12 Months Ended
	Apr. 30, 2021	Dec. 31, 2020	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Acquisitions [Abstract]
Purchase price, net of cash acquired			$ 18,963	$ 14,949	$ 8,073
Accrued liability		$ 40,768	31,111	40,768
Fair Value of Assets Acquired [Abstract]
Goodwill		$ 202,979	$ 206,432	$ 202,979
Useful life			14 years
Trademarks [Member]
Fair Value of Assets Acquired [Abstract]
Useful life			10 years
3i [Member]
Acquisitions [Abstract]
Percentage interest acquired		100.00%		100.00%
Purchase price, net of cash acquired		$ 15,700
Cash acquired		2,100
Accrued liability		800		$ 800
Incremental contingent consideration		7,000		7,000
Contingent consideration		3,100		3,100
Gross purchase price		24,500		24,500
Fair Value of Assets Acquired [Abstract]
Intangible assets		14,400		14,400
Property and equipment		300		300
Cash		2,100		2,100
Accounts receivable		800		800
Current liabilities		300		300
Deferred tax liability		3,100		3,100
Goodwill		6,400		6,400
Useful life			8 years
3i [Member] | Maximum [Member]
Fair Value of Assets Acquired [Abstract]
Inventory		300		300
3i [Member] | Customer Relationships [Member]
Fair Value of Assets Acquired [Abstract]
Intangible assets		3,700		3,700
3i [Member] | Technology [Member]
Fair Value of Assets Acquired [Abstract]
Intangible assets		10,000		10,000
3i [Member] | Other Intangibles [Member]
Fair Value of Assets Acquired [Abstract]
Intangible assets		$ 700		$ 700
Mavely [Member]
Acquisitions [Abstract]
Percentage interest acquired	100.00%
Purchase price, net of cash acquired	$ 16,800
Cash acquired	400
Accrued liability	900
Incremental contingent consideration	24,000
Contingent consideration	8,700
Gross purchase price	29,400
Fair Value of Assets Acquired [Abstract]
Intangible assets	16,400
Cash	400
Accounts receivable	100
Deferred tax liability	3,500
Goodwill	12,600
Mavely [Member] | Customer Relationships [Member]
Fair Value of Assets Acquired [Abstract]
Intangible assets	2,000
Useful life			4 years
Mavely [Member] | Technology [Member]
Fair Value of Assets Acquired [Abstract]
Intangible assets	11,300
Useful life			8 years
Mavely [Member] | Trademarks [Member]
Fair Value of Assets Acquired [Abstract]
Intangible assets	2,800
Useful life			8 years
Mavely [Member] | Other Intangibles [Member]
Fair Value of Assets Acquired [Abstract]
Intangible assets	$ 300
Useful life			3 years

Restructuring and Severance C_2

Restructuring and Severance Charges (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Restructuring and Severance Charges [Abstract]
Non-cash impairment charges	$ 51,870	$ 0	$ 0
Impairment of fixed assets	13,700
Accrued Liabilities [Member]
Restructuring and Severance Charges [Abstract]
Liability related to cash charges	20,000
Grow Tech [Member]
Restructuring and Severance Charges [Abstract]
Non-cash impairment charges	38,500
Impairment of goodwill	9,200
Impairment of intangible assets	9,000
Impairment of fixed assets	13,700
Inventory write-off	6,600
Cash charges associated with restructuring	20,000
Employee severance	6,500
Other related restructuring charges	$ 13,500